Document_and_Entity_Informatio
Document and Entity Information | 9 Months Ended |
Sep. 30, 2013 | |
Entity Information [Line Items] | |
Entity Registrant Name | COLGATE PALMOLIVE CO |
Entity Central Index Key | 21665 |
Current Fiscal Year End Date | -19 |
Entity Well-known Seasoned Issuer | Yes |
Entity Voluntary Filers | No |
Entity Current Reporting Status | Yes |
Entity Filer Category | Large Accelerated Filer |
Entity Common Stock, Shares Outstanding | 925,208,785 |
Document Fiscal Year Focus | 2013 |
Document Fiscal Period Focus | Q3 |
Document Type | 10-Q |
Amendment Flag | FALSE |
Document Period End Date | 30-Sep-13 |
CONDENSED_CONSOLIDATED_STATEME
CONDENSED CONSOLIDATED STATEMENTS OF INCOME (Unaudited) (USD $) | 3 Months Ended | 9 Months Ended | ||
In Millions, except Per Share data, unless otherwise specified | Sep. 30, 2013 | Sep. 30, 2012 | Sep. 30, 2013 | Sep. 30, 2012 |
Net sales | $4,398 | $4,332 | $13,059 | $12,799 |
Cost of sales | 1,813 | 1,803 | 5,425 | 5,372 |
Gross profit | 2,585 | 2,529 | 7,634 | 7,427 |
Selling, general and administrative expenses | 1,549 | 1,501 | 4,611 | 4,443 |
Other (income) expense, net | 20 | 1 | 359 | 37 |
Operating profit | 1,016 | 1,027 | 2,664 | 2,947 |
Interest (income) expense, net | 0 | 4 | -8 | 20 |
Income before income taxes | 1,016 | 1,023 | 2,672 | 2,927 |
Provision for income taxes | 317 | 326 | 863 | 932 |
Net income including noncontrolling interests | 699 | 697 | 1,809 | 1,995 |
Less: Net income attributable to noncontrolling interests | 43 | 43 | 132 | 121 |
Net income attributable to Colgate-Palmolive Company | $656 | $654 | $1,677 | $1,874 |
Earnings per common share, basic (in dollars per share) | $0.71 | $0.69 | $1.80 | $1.96 |
Earnings per common share, diluted (in dollars per share) | $0.70 | $0.68 | $1.78 | $1.95 |
Dividends declared per common share (in dollars per share) | $0.34 | $0.31 | $1.33 | $0.91 |
CONDENSED_CONSOLIDATED_STATEME1
CONDENSED CONSOLIDATED STATEMENTS OF COMPREHENSIVE INCOME (Unaudited) (USD $) | 3 Months Ended | 9 Months Ended | ||
In Millions, unless otherwise specified | Sep. 30, 2013 | Sep. 30, 2012 | Sep. 30, 2013 | Sep. 30, 2012 |
Net income including noncontrolling interests | $699 | $697 | $1,809 | $1,995 |
Other comprehensive income, net of tax: | ||||
Cumulative translation adjustments | 90 | 89 | -165 | -23 |
Retirement Plan and other retiree benefit adjustments | 18 | 25 | 56 | 35 |
Gains (losses) on available-for-sale securities | 3 | -5 | 7 | 9 |
Unrealized gains (losses) on cash flow hedges | -5 | -2 | 0 | 3 |
Total Other comprehensive (loss) income, net of tax | 106 | 107 | -102 | 24 |
Total Comprehensive income including noncontrolling interests | 805 | 804 | 1,707 | 2,019 |
Less: Net income attributable to noncontrolling interests | 43 | 43 | 132 | 121 |
Less: Cumulative translation adjustments attributable to noncontrolling interests | -3 | 8 | -7 | 4 |
Total Comprehensive Income attributable to noncontrolling interests | 40 | 51 | 125 | 125 |
Total Comprehensive income attributable to Colgate-Palmolive Company | $765 | $753 | $1,582 | $1,894 |
CONDENSED_CONSOLIDATED_BALANCE
CONDENSED CONSOLIDATED BALANCE SHEETS (Unaudited) (USD $) | Sep. 30, 2013 | Dec. 31, 2012 |
In Millions, unless otherwise specified | ||
Current Assets | ||
Cash and cash equivalents | $721 | $884 |
Receivables (net of allowances of $65 and $61, respectively) | 1,737 | 1,668 |
Inventories | 1,441 | 1,365 |
Other current assets | 701 | 639 |
Total current assets | 4,600 | 4,556 |
Property, plant and equipment: | ||
Cost | 8,051 | 7,821 |
Less: Accumulated depreciation | -4,193 | -3,979 |
Property, plant and equipment, net | 3,858 | 3,842 |
Goodwill, net | 2,471 | 2,500 |
Other intangible assets, net | 1,487 | 1,499 |
Deferred income taxes | 91 | 92 |
Other assets | 932 | 905 |
Total assets | 13,439 | 13,394 |
Current Liabilities | ||
Notes and loans payable | 19 | 54 |
Current portion of long-term debt | 588 | 250 |
Accounts payable | 1,234 | 1,290 |
Accrued income taxes | 283 | 254 |
Other accruals | 2,367 | 1,888 |
Total current liabilities | 4,491 | 3,736 |
Long-term debt | 4,677 | 4,926 |
Deferred income taxes | 312 | 293 |
Other liabilities | 1,952 | 2,049 |
Shareholders' Equity | ||
Common stock | 1,466 | 1,466 |
Additional paid-in capital | 912 | 818 |
Retained earnings | 17,393 | 16,953 |
Accumulated other comprehensive income (loss) | -2,716 | -2,621 |
Unearned compensation | -35 | -41 |
Treasury stock, at cost | -15,236 | -14,386 |
Total Colgate-Palmolive Company shareholders' equity | 1,784 | 2,189 |
Noncontrolling interests | 223 | 201 |
Total shareholders' equity | 2,007 | 2,390 |
Total liabilities and shareholders' equity | $13,439 | $13,394 |
CONDENSED_CONSOLIDATED_BALANCE1
CONDENSED CONSOLIDATED BALANCE SHEETS (Unaudited) (Parentheticals) (USD $) | Sep. 30, 2013 | Dec. 31, 2012 |
In Millions, unless otherwise specified | ||
Statement of Financial Position [Abstract] | ||
Allowance for doubtful accounts | $65 | $61 |
CONDENSED_CONSOLIDATED_STATEME2
CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS (Unaudited) (USD $) | 9 Months Ended | |
In Millions, unless otherwise specified | Sep. 30, 2013 | Sep. 30, 2012 |
Operating Activities | ||
Net income including noncontrolling interests | $1,809 | $1,995 |
Adjustments to reconcile net income including noncontrolling interests to net cash provided by operations: | ||
Depreciation and amortization | 329 | 317 |
Restructuring and termination benefits, net of cash | 82 | -35 |
Voluntary benefit plan contributions | -101 | -101 |
Stock-based compensation expense | 105 | 98 |
Venezuela devaluation charge | 172 | 0 |
Deferred income taxes | 35 | 71 |
Cash effects of changes in: | ||
Receivables | -137 | -166 |
Inventories | -107 | -48 |
Accounts payable and other accruals | 121 | -27 |
Other non-current assets and liabilities | 57 | 29 |
Net cash provided by operations | 2,365 | 2,133 |
Investing Activities | ||
Capital expenditures | -419 | -317 |
Sale of property and non-core product lines | 0 | 38 |
Purchases of marketable securities and investments | -408 | -501 |
Proceeds from sale of marketable securities and investments | 195 | 120 |
Payments for acquisitions, net of cash acquired | 0 | -29 |
Other | 4 | 65 |
Net cash used in investing activities | -628 | -624 |
Financing Activities | ||
Principal payments on debt | -5,504 | -3,684 |
Proceeds from issuance of debt | 5,563 | 4,131 |
Dividends paid | -1,030 | -951 |
Purchases of treasury shares | -1,115 | -1,344 |
Proceeds from exercise of stock options and excess tax benefits | 276 | 390 |
Net cash used in financing activities | -1,810 | -1,458 |
Effect of exchange rate changes on Cash and cash equivalents | -90 | -20 |
Net increase (decrease) in Cash and cash equivalents | -163 | 31 |
Cash and cash equivalents at beginning of the period | 884 | 878 |
Cash and cash equivalents at end of the period | 721 | 909 |
Supplemental Cash Flow Information | ||
Income taxes paid | $781 | $949 |
Basis_of_Presentation
Basis of Presentation | 9 Months Ended |
Sep. 30, 2013 | |
Notes to Financial Statements [Abstract] | |
Basis of Presentation | Basis of Presentation |
The Condensed Consolidated Financial Statements reflect all normal recurring adjustments which, in management’s opinion, are necessary for a fair statement of the results for interim periods. Results of operations for interim periods may not be representative of results to be expected for a full year. Certain prior year amounts have been reclassified to conform to the current year presentation. | |
For a complete set of financial statement notes, including the significant accounting policies of Colgate-Palmolive Company (together with its subsidiaries, the “Company” or “Colgate”), refer to the Company’s Annual Report on Form 10-K for the year ended December 31, 2012, filed with the Securities and Exchange Commission. |
Use_of_Estimates
Use of Estimates | 9 Months Ended |
Sep. 30, 2013 | |
Notes to Financial Statements [Abstract] | |
Use of Estimates | Use of Estimates |
Provisions for certain expenses, including income taxes, media advertising and consumer promotion, are based on full year assumptions and are included in the accompanying Condensed Consolidated Financial Statements in proportion with estimated annual tax rates, the passage of time or estimated annual sales. |
Recent_Accounting_Pronouncemen
Recent Accounting Pronouncements | 9 Months Ended |
Sep. 30, 2013 | |
New Accounting Pronouncements and Changes in Accounting Principles [Abstract] | |
New Accounting Pronouncements and Changes in Accounting Principles [Text Block] | Recent Accounting Pronouncements |
In July 2013, the Financial Accounting Standards Board (FASB) issued Accounting Standards Update (ASU) No. 2013-10 “Inclusion of the Fed Funds Effective Swap Rate (or Overnight Index Swap Rate) as a Benchmark Interest Rate for Hedge Accounting Purposes”. ASU No. 2013-10 permits the Fed Funds Effective Swap Rate to be used as a benchmark interest rate for hedge accounting purposes and eliminates the restriction on using different benchmark interest rates for similar hedges. The new guidance is effective immediately and can be applied prospectively for qualifying new or redesignated hedging relationships entered into on or after July 17, 2013. This new guidance is not expected to have a material impact on the Company’s financial position or results of operations. | |
In July 2013, the FASB issued ASU No. 2013-11 “Presentation of an Unrecognized Tax Benefit When a Net Operating Loss Carryforward, a Similar Tax Loss, or a Tax Credit Carryforward Exists”. ASU No. 2013-11 requires an entity to net its liability for unrecognized tax benefits against the deferred tax assets for all same jurisdiction net operating losses or similar tax loss carryforwards, or tax credit carryforwards. A gross presentation will be required only if such carryforwards are not available as of reporting date to settle any additional income taxes resulting from disallowance of the uncertain tax position or the entity does not intend to use these carryforwards for this purpose. The new guidance is effective on a prospective basis for fiscal years beginning after December 15, 2013 and interim periods within those years. This new guidance is not expected to have a material impact on the Company’s financial position or results of operations. |
Acquisitions_and_Divestitures
Acquisitions and Divestitures | 9 Months Ended |
Sep. 30, 2013 | |
Notes to Financial Statements [Abstract] | |
Acquisitions and Divestitures | Acquisitions and Divestitures |
Sale of Land in Mexico | |
On September 13, 2011, the Company’s Mexican subsidiary entered into an agreement to sell to the United States of America the Mexico City site on which its commercial operations, technology center and soap production facility are located. The sale price is payable in three installments, with the final installment due upon the transfer of the property, which is expected to occur in 2014. During the third quarter of 2011, the Company received the first installment of $24 upon signing the agreement. During the third quarter of 2012, the Company received the second installment of $36. The Company is re-investing these payments to relocate its soap production to a new state-of-the-art facility to be constructed at its Mission Hills, Mexico site, to relocate its commercial and technology operations within Mexico City and to prepare the existing site for transfer. As a result, the Company expects to make capital improvements and incur costs to exit the site through 2014. These exit costs will primarily be related to staff leaving indemnities, accelerated depreciation and demolition to make the site building-ready. During the three months ended September 30, 2013 and 2012, the Company incurred $3 and $7 of pretax costs ($2 and $5 of aftertax costs), respectively, related to the sale. During the nine months ended September 30, 2013 and 2012, the Company incurred $14 and $20 of pretax costs ($9 and $15 of aftertax costs), respectively, related to the sale. |
Restructuring_and_Related_Impl
Restructuring and Related Implementation Charges | 9 Months Ended | ||||||||||||||||||||
Sep. 30, 2013 | |||||||||||||||||||||
Restructuring and Related Activities [Abstract] | |||||||||||||||||||||
Restructuring and Related Implementation Charges | Restructuring and Related Implementation Charges | ||||||||||||||||||||
In the fourth quarter of 2012, the Company commenced a four-year Global Growth and Efficiency Program (the 2012 Restructuring Program) for sustained growth. The program’s initiatives are expected to help Colgate ensure continued solid worldwide growth in unit volume, organic sales and earnings per share and enhance its global leadership positions in its core businesses. | |||||||||||||||||||||
Implementation of the 2012 Restructuring Program is projected to result in cumulative pretax charges, once all phases are approved and implemented, totaling between $1,100 and $1,250 ($775 and $875 aftertax), which are currently estimated to be comprised of the following categories: Employee-Related Costs, including severance, pension and other termination benefits (50%); asset-related costs, primarily Incremental Depreciation and Asset Impairments (15%); and Other charges, which include contract termination costs, consisting primarily of implementation-related charges resulting directly from exit activities (20%) and the implementation of new strategies (15%). Due to the acceleration of the implementation of certain program initiatives, the anticipated pretax charges for 2013 increased to approximately $365 to $390 ($290 to $305 aftertax) from approximately $260 to $310 ($185 to $220 aftertax) with no change to the amount of expected total program charges. Over the course of the 2012 Restructuring Program, it is estimated that approximately 75% of the charges will result in cash expenditures. | |||||||||||||||||||||
It is expected that the cumulative pretax charges, once all projects are approved and implemented, will relate to initiatives undertaken in North America (15%), Europe/South Pacific (20%), Latin America (5%), Asia (5%), Africa/Eurasia (5%), Hill’s Pet Nutrition (10%) and Corporate (40%), which includes substantially all of the costs related to the implementation of new strategies, noted above, on a global basis. | |||||||||||||||||||||
For the three and nine months ended September 30, 2013, restructuring and implementation-related charges are reflected in the income statement as follows: | |||||||||||||||||||||
Three Months Ended | Nine Months Ended | ||||||||||||||||||||
30-Sep-13 | 30-Sep-13 | ||||||||||||||||||||
Cost of sales | $ | 8 | $ | 26 | |||||||||||||||||
Selling, general and administrative expenses | 9 | 31 | |||||||||||||||||||
Other (income) expense, net | 13 | 141 | |||||||||||||||||||
Total 2012 Restructuring Program charges, pretax | $ | 30 | $ | 198 | |||||||||||||||||
Total 2012 Restructuring Program charges, aftertax | $ | 22 | $ | 153 | |||||||||||||||||
Restructuring and related implementation charges in the preceding table are recorded in the Corporate segment as these initiatives are predominantly centrally directed and controlled and are not included in internal measures of segment operating performance. Total charges for the 2012 Restructuring Program for the three months ended September 30, 2013 relate to initiatives undertaken in North America (13%), Europe/South Pacific (22%), Latin America (6%), Hill’s Pet Nutrition (29%) and Corporate (30%). Total charges for the 2012 Restructuring Program for the nine months ended September 30, 2013 relate to initiatives undertaken in North America (20%), Europe/South Pacific (35%), Latin America (6%), Africa/Eurasia (4%), Hill's Pet Nutrition (8%) and Corporate (27%). Total program-to-date accumulated charges for the 2012 Restructuring Program relate to initiatives undertaken in North America (14%), Europe/South Pacific (42%), Latin America (4%), Africa/Eurasia (3%), Hill's Pet Nutrition (6%) and Corporate (31%). | |||||||||||||||||||||
Since the inception of the 2012 Restructuring Program in the fourth quarter of 2012, the Company has incurred pretax cumulative charges of $287 ($223 aftertax) in connection with the implementation of various projects as follows: | |||||||||||||||||||||
Cumulative Charges | |||||||||||||||||||||
as of September 30, 2013 | |||||||||||||||||||||
Employee-Related Costs | $ | 169 | |||||||||||||||||||
Incremental Depreciation | 20 | ||||||||||||||||||||
Asset Impairments | 1 | ||||||||||||||||||||
Other | 97 | ||||||||||||||||||||
Total | $ | 287 | |||||||||||||||||||
The majority of costs incurred since inception relate to the following projects: the closing of the Morristown, New Jersey personal care facility; the simplification and streamlining of the Company's research and development capabilities and oral care supply chain, both in Europe; other exit costs related to office consolidation; and the restructuring of certain commercial operations in advance of implementing an overall hubbing strategy. | |||||||||||||||||||||
The following tables summarize the activity for the restructuring and implementation-related charges discussed above and the related accrual: | |||||||||||||||||||||
Three Months Ended September 30, 2013 | |||||||||||||||||||||
Employee-Related | Incremental | Asset | Other | Total | |||||||||||||||||
Costs | Depreciation | Impairments | |||||||||||||||||||
Balance at June 30, 2013 | $ | 141 | $ | — | $ | — | $ | 31 | $ | 172 | |||||||||||
Charges | 5 | 5 | — | 20 | 30 | ||||||||||||||||
Cash payments | (40 | ) | — | — | (11 | ) | (51 | ) | |||||||||||||
Charges against assets | — | (5 | ) | — | — | (5 | ) | ||||||||||||||
Foreign exchange | — | — | — | — | — | ||||||||||||||||
Balance at September 30, 2013 | $ | 106 | $ | — | $ | — | $ | 40 | $ | 146 | |||||||||||
Nine Months Ended September 30, 2013 | |||||||||||||||||||||
Employee-Related | Incremental | Asset | Other | Total | |||||||||||||||||
Costs | Depreciation | Impairments | |||||||||||||||||||
Balance at December 31, 2012 | $ | 84 | $ | — | $ | — | $ | 5 | $ | 89 | |||||||||||
Charges | 91 | 20 | 1 | 86 | 198 | ||||||||||||||||
Cash payments | (52 | ) | — | — | (51 | ) | (103 | ) | |||||||||||||
Charges against assets | (17 | ) | (20 | ) | (1 | ) | — | (38 | ) | ||||||||||||
Foreign exchange | — | — | — | — | — | ||||||||||||||||
Balance at September 30, 2013 | $ | 106 | $ | — | $ | — | $ | 40 | $ | 146 | |||||||||||
Employee-related costs primarily include severance and other termination benefits and are calculated based on long-standing benefit practices, local statutory requirements and, in certain cases, voluntary termination arrangements. Employee-related costs also include pension and other retiree benefit enhancements amounting to $17 for the nine months ended September 30, 2013, which are reflected as Charges against assets within Employee-related costs in the preceding tables as the corresponding balance sheet amounts are reflected as a reduction of pension assets or an increase in pension and other retiree benefit liabilities. | |||||||||||||||||||||
Incremental depreciation is recorded to reflect changes in useful lives and estimated residual values for long-lived assets that will be taken out of service prior to the end of their normal service period. Asset impairments are recorded to write down assets held for sale or disposal to their fair value based on amounts expected to be realized. Asset impairments are net of cash proceeds pertaining to the sale of certain assets. | |||||||||||||||||||||
Other charges consist primarily of implementation-related charges resulting directly from exit activities and the implementation of new strategies as a result of the 2012 Restructuring Program. These charges for the three and nine months ended September 30, 2013 included third-party incremental costs related to the development and implementation of new business and strategic initiatives of $11 and $35, respectively, and contract termination costs of $8 and $27, respectively, directly related to the 2012 Restructuring Program. These charges were expensed as incurred. These charges, for the nine months ended September 30, 2013, also included a charge for other exit costs related to office space consolidation of $24. |
Inventories
Inventories | 9 Months Ended | |||||||
Sep. 30, 2013 | ||||||||
Inventory, Net [Abstract] | ||||||||
Inventories | Inventories | |||||||
Inventories by major class are as follows: | ||||||||
September 30, | December 31, | |||||||
2013 | 2012 | |||||||
Raw materials and supplies | $ | 340 | $ | 362 | ||||
Work-in-process | 58 | 81 | ||||||
Finished goods | 1,043 | 922 | ||||||
Total Inventories | $ | 1,441 | $ | 1,365 | ||||
Shareholders_Equity
Shareholders' Equity | 9 Months Ended | |||||||||||||||||||||||||||
Sep. 30, 2013 | ||||||||||||||||||||||||||||
Notes to Financial Statements [Abstract] | ||||||||||||||||||||||||||||
Shareholders' Equity | Shareholders’ Equity | |||||||||||||||||||||||||||
Changes in the components of Shareholders’ Equity for the nine months ended September 30, 2013 are as follows: | ||||||||||||||||||||||||||||
Colgate-Palmolive Company Shareholders’ Equity | Noncontrolling | |||||||||||||||||||||||||||
Interests | ||||||||||||||||||||||||||||
Common | Additional | Unearned | Treasury | Retained | Accumulated | |||||||||||||||||||||||
Stock | Paid-in | Compensation | Stock | Earnings | Other | |||||||||||||||||||||||
Capital | Comprehensive | |||||||||||||||||||||||||||
Income (Loss) | ||||||||||||||||||||||||||||
Balance, December 31, 2012 | $ | 1,466 | $ | 818 | $ | (41 | ) | $ | (14,386 | ) | $ | 16,953 | $ | (2,621 | ) | $ | 201 | |||||||||||
Net income | 1,677 | 132 | ||||||||||||||||||||||||||
Other comprehensive income, net of tax | (95 | ) | (7 | ) | ||||||||||||||||||||||||
Dividends | (1,237 | ) | (108 | ) | ||||||||||||||||||||||||
Stock-based compensation expense | 105 | |||||||||||||||||||||||||||
Shares issued for stock options | 64 | 195 | ||||||||||||||||||||||||||
Shares issued for restricted stock awards | (72 | ) | 72 | |||||||||||||||||||||||||
Treasury stock acquired | (1,115 | ) | ||||||||||||||||||||||||||
Other | (3 | ) | 6 | (2 | ) | 5 | ||||||||||||||||||||||
Balance, September 30, 2013 | $ | 1,466 | $ | 912 | $ | (35 | ) | $ | (15,236 | ) | $ | 17,393 | $ | (2,716 | ) | $ | 223 | |||||||||||
Accumulated other comprehensive income (loss) includes cumulative foreign currency translation losses of $1,767 and $1,609 at September 30, 2013 and December 31, 2012, respectively, and unrecognized pension and other retiree benefit costs of $997 and $1,053 at September 30, 2013 and December 31, 2012, respectively. |
Earnings_Per_Share
Earnings Per Share | 9 Months Ended | |||||||||||||||||||||
Sep. 30, 2013 | ||||||||||||||||||||||
Earnings Per Share [Abstract] | ||||||||||||||||||||||
Earnings Per Share | Earnings Per Share | |||||||||||||||||||||
Three Months Ended | ||||||||||||||||||||||
September 30, 2013 | September 30, 2012 | |||||||||||||||||||||
Net income attributable to Colgate-Palmolive Company | Shares | Per | Net income attributable to Colgate-Palmolive Company | Shares | Per | |||||||||||||||||
(millions) | Share | (millions) | Share | |||||||||||||||||||
Basic EPS | $ | 656 | 928.1 | $ | 0.71 | $ | 654 | 949.8 | $ | 0.69 | ||||||||||||
Stock options and | 8.8 | 8.6 | ||||||||||||||||||||
restricted stock | ||||||||||||||||||||||
Diluted EPS | $ | 656 | 936.9 | $ | 0.7 | $ | 654 | 958.4 | $ | 0.68 | ||||||||||||
For the three months ended September 30, 2013 and 2012, the average number of stock options and restricted stock awards that were anti-dilutive and not included in diluted earnings per share calculations were 1,956,750 and 1,214,526, respectively. | ||||||||||||||||||||||
Nine Months Ended | ||||||||||||||||||||||
September 30, 2013 | September 30, 2012 | |||||||||||||||||||||
Net income attributable to Colgate-Palmolive Company | Shares | Per | Net income attributable to Colgate-Palmolive Company | Shares | Per | |||||||||||||||||
(millions) | Share | (millions) | Share | |||||||||||||||||||
Basic EPS | $ | 1,677 | 932.5 | $ | 1.8 | $ | 1,874 | 954.8 | $ | 1.96 | ||||||||||||
Stock options and | 8.9 | 8.1 | ||||||||||||||||||||
restricted stock | ||||||||||||||||||||||
Diluted EPS | $ | 1,677 | 941.4 | $ | 1.78 | $ | 1,874 | 962.9 | $ | 1.95 | ||||||||||||
For the nine months ended September 30, 2013 and 2012, the average number of stock options and restricted stock awards that were anti-dilutive and not included in diluted earnings per share calculations were 703,219 and 1,259,888, respectively. | ||||||||||||||||||||||
As a result of the two-for-one stock split effective May 15, 2013, see Note 9, Common Stock Split, all historical per share data and number of shares were retroactively adjusted. Basic and diluted earnings per share were computed independently for each quarter and the year-to-date period presented. As a result of the stock split, changes in shares outstanding during the year and rounding, the sum of the quarters' earnings per share may not necessarily equal the earnings per share for the year-to-date period. |
Common_Stock_Split
Common Stock Split | 9 Months Ended |
Sep. 30, 2013 | |
Common Stock Split [Abstract] | |
Common Stock Split Note Disclosure | Common Stock Split |
On March 7, 2013, the Company's Board of Directors approved a two-for-one stock split of the Company's common stock to be effected through a 100% stock dividend. The record date for the two-for-one split was the close of business on April 23, 2013, and the share distribution occurred on May 15, 2013. As a result of the split, shareholders received one additional share of Colgate common stock, par value $1.00, for each share they held as of the record date. | |
All per share amounts and number of shares outstanding in these Condensed Consolidated Financial Statements and Notes to the Condensed Consolidated Financial Statements are presented on a post-split basis. | |
In addition, the impact on the Balance Sheet as a result of the stock split was an increase of $733 to Common Stock and an offsetting reduction in Additional paid-in capital, which has been retroactively restated. |
Other_Comprehensive_Income
Other Comprehensive Income | 9 Months Ended | ||||||||||||||
Sep. 30, 2013 | |||||||||||||||
Other Comprehensive Income (Loss) [Abstract] | |||||||||||||||
Comprehensive Income (Loss) Note | Other Comprehensive Income (Loss) | ||||||||||||||
Additions to and reclassifications out of Accumulated other comprehensive income (loss) attributable to the Company for the three months ended September 30, 2013 and 2012 were as follows: | |||||||||||||||
2013 | 2012 | ||||||||||||||
Pre-tax | Net of Tax | Pre-tax | Net of Tax | ||||||||||||
Cumulative translation adjustments | $ | 82 | $ | 93 | $ | 79 | $ | 81 | |||||||
Pension and other benefits: | |||||||||||||||
Net actuarial gains (losses) and prior service costs arising during the period | 1 | 1 | 13 | 8 | |||||||||||
Amortization of net actuarial losses, transition and prior service costs (1) | 27 | 17 | 27 | 17 | |||||||||||
Retirement Plan and other retiree benefit adjustments | 28 | 18 | 40 | 25 | |||||||||||
Available-for-sale securities: | |||||||||||||||
Unrealized gains (losses) on available-for-sale securities | 4 | 3 | (8 | ) | (5 | ) | |||||||||
Reclassification of (gains) losses into net earnings on available-for-sale securities | — | — | — | — | |||||||||||
Gains (losses) on available-for-sale securities | 4 | 3 | (8 | ) | (5 | ) | |||||||||
Cash flow hedges: | |||||||||||||||
Unrealized gains (losses) on cash flow hedges | 2 | — | (1 | ) | — | ||||||||||
Reclassification of (gains) losses into net earnings on cash flow hedges (2) | (8 | ) | (5 | ) | (3 | ) | (2 | ) | |||||||
Gains (losses) on cash flow hedges | (6 | ) | (5 | ) | (4 | ) | (2 | ) | |||||||
Total Other comprehensive income (loss) | $ | 108 | $ | 109 | $ | 107 | $ | 99 | |||||||
(1)These components of Other comprehensive income (loss) are included in the computation of net periodic benefit cost. See Note 11, Retirement Plans and Other Retiree Benefits for additional details. | |||||||||||||||
(2)These (gains) losses are reclassified into Cost of sales. See Note 14, Fair Value Measurements and Financial Instruments for additional details. | |||||||||||||||
Additions to and reclassifications out of Accumulated other comprehensive income (loss) attributable to the Company for the nine months ended September 30, 2013 and 2012 were as follows: | |||||||||||||||
2013 | 2012 | ||||||||||||||
Pre-tax | Net of Tax | Pre-tax | Net of Tax | ||||||||||||
Cumulative translation adjustments | $ | (170 | ) | $ | (158 | ) | $ | (26 | ) | $ | (27 | ) | |||
Pension and other benefits: | |||||||||||||||
Net actuarial gains (losses) and prior service costs arising during the period | 4 | 3 | (19 | ) | (14 | ) | |||||||||
Amortization of net actuarial losses, transition and prior service costs (1) | 82 | 53 | 76 | 49 | |||||||||||
Retirement Plan and other retiree benefit adjustments | 86 | 56 | 57 | 35 | |||||||||||
Available-for-sale securities: | |||||||||||||||
Unrealized gains (losses) on available-for-sale securities | (124 | ) | (79 | ) | 14 | 9 | |||||||||
Reclassification of (gains) losses into net earnings on available-for-sale securities (2) | 133 | 86 | — | — | |||||||||||
Gains (losses) on available-for-sale securities | 9 | 7 | 14 | 9 | |||||||||||
Cash flow hedges: | |||||||||||||||
Unrealized gains (losses) on cash flow hedges | 13 | 8 | 7 | 5 | |||||||||||
Reclassification of (gains) losses into net earnings on cash flow hedges (3) | (13 | ) | (8 | ) | (4 | ) | (2 | ) | |||||||
Gains (losses) on cash flow hedges | — | — | 3 | 3 | |||||||||||
Total Other comprehensive income (loss) | $ | (75 | ) | $ | (95 | ) | $ | 48 | $ | 20 | |||||
(1)These components of Other comprehensive income (loss) are included in the computation of net periodic benefit cost. See Note 11, Retirement Plans and Other Retiree Benefits for additional details. | |||||||||||||||
(2)Represents the one-time loss related to the remeasurement of the fixed interest rate bonds in Venezuela which was recorded in Other (income) expense, net. See Note 14, Fair Value Measurements and Financial Instruments for additional details. | |||||||||||||||
(3)These (gains) losses are reclassified into Cost of sales. See Note 14, Fair Value Measurements and Financial Instruments for additional details. |
Retirement_Plans_and_Other_Ret
Retirement Plans and Other Retiree Benefits | 9 Months Ended | |||||||||||||||||||||||
Sep. 30, 2013 | ||||||||||||||||||||||||
Notes to Financial Statements [Abstract] | ||||||||||||||||||||||||
Retirement Plans and Other Retiree Benefits | Retirement Plans and Other Retiree Benefits | |||||||||||||||||||||||
Components of Net periodic benefit cost for the three-month and nine-month periods ended September 30, 2013 and 2012 were as follows: | ||||||||||||||||||||||||
Pension Benefits | Other Retiree Benefits | |||||||||||||||||||||||
United States | International | |||||||||||||||||||||||
Three Months Ended September 30, | ||||||||||||||||||||||||
2013 | 2012 | 2013 | 2012 | 2013 | 2012 | |||||||||||||||||||
Service cost | $ | 6 | $ | 4 | $ | 6 | $ | 6 | $ | 3 | $ | 2 | ||||||||||||
Interest cost | 22 | 24 | 8 | 9 | 8 | 9 | ||||||||||||||||||
ESOP offset | — | — | — | — | — | — | ||||||||||||||||||
Expected return on plan assets | (29 | ) | (28 | ) | (7 | ) | (7 | ) | (1 | ) | (1 | ) | ||||||||||||
Amortization of transition and prior service costs (credits) | 1 | 2 | 1 | 1 | — | — | ||||||||||||||||||
Amortization of actuarial loss | 17 | 17 | 3 | 2 | 5 | 5 | ||||||||||||||||||
Net periodic benefit cost | $ | 17 | $ | 19 | $ | 11 | $ | 11 | $ | 15 | $ | 15 | ||||||||||||
Pension Benefits | Other Retiree Benefits | |||||||||||||||||||||||
United States | International | |||||||||||||||||||||||
Nine Months Ended September 30, | ||||||||||||||||||||||||
2013 | 2012 | 2013 | 2012 | 2013 | 2012 | |||||||||||||||||||
Service cost | $ | 20 | $ | 18 | $ | 16 | $ | 17 | $ | 10 | $ | 8 | ||||||||||||
Interest cost | 68 | 73 | 22 | 26 | 28 | 30 | ||||||||||||||||||
ESOP offset | — | — | — | — | (1 | ) | (1 | ) | ||||||||||||||||
Expected return on plan assets | (88 | ) | (84 | ) | (19 | ) | (19 | ) | (2 | ) | (2 | ) | ||||||||||||
Amortization of transition and prior service costs (credits) | 6 | 7 | 1 | 1 | — | 2 | ||||||||||||||||||
Amortization of actuarial loss | 49 | 46 | 10 | 7 | 16 | 13 | ||||||||||||||||||
Net periodic benefit cost | $ | 55 | $ | 60 | $ | 30 | $ | 32 | $ | 51 | $ | 50 | ||||||||||||
For each of the nine months ended September 30, 2013 and 2012, the Company made voluntary contributions of $101 to its U.S. postretirement plans. |
Contingencies
Contingencies | 9 Months Ended | |
Sep. 30, 2013 | ||
Notes to Financial Statements [Abstract] | ||
Contingencies | Contingencies | |
As a global company serving consumers in more than 200 countries and territories, the Company is routinely subject to a wide variety of legal proceedings. These include disputes relating to intellectual property, contracts, product liability, marketing, advertising, foreign exchange controls, antitrust and trade regulation, as well as labor and employment, environmental and tax matters. Management proactively reviews and monitors the Company’s exposure to, and the impact of, environmental matters. The Company is party to various environmental matters and, as such, may be responsible for all or a portion of the cleanup, restoration and post-closure monitoring of several sites. | ||
As a matter of course, the Company is regularly audited by the IRS and other tax authorities around the world in countries where it conducts business. In this regard, all U.S. federal income tax returns through December 31, 2007 have been audited by the IRS and there are limited matters in administrative appeals for years 2002 through 2007, the settlement of which is not expected to have a material adverse effect on the Company’s results of operations, cash flows or financial condition. With a few exceptions, the Company is no longer subject to U.S., state and local income tax examinations for the years prior to 2007. In addition, the Company has subsidiaries in various foreign jurisdictions that have statutes of limitations for tax audits generally ranging from three to six years. Estimated incremental tax payments related to potential disallowances for subsequent periods are not expected to be material. | ||
The Company establishes accruals for loss contingencies when it has determined that a loss is probable and that the amount of loss, or range of loss, can be reasonably estimated. Any such accruals are adjusted thereafter as appropriate to reflect changes in circumstances. | ||
The Company also determines estimates of reasonably possible losses or ranges of reasonably possible losses in excess of related accrued liabilities, if any, when it has determined that a loss is reasonably possible and it is able to determine such estimates. For those matters disclosed below, the Company currently estimates that the aggregate range of reasonably possible losses in excess of any accrued liabilities is $0 to approximately $250 (based on current exchange rates). The estimates included in this amount are based on the Company’s analysis of currently available information and, as new information is obtained, these estimates may change. Due to the inherent subjectivity of the assessments and the unpredictability of outcomes of legal proceedings, any amounts accrued or included in this aggregate amount may not represent the ultimate loss to the Company from the matters in question. Thus, the Company’s exposure and ultimate losses may be higher or lower, and possibly significantly so, than the amounts accrued or the range disclosed above. | ||
Based on current knowledge, management does not believe that the ultimate resolution of loss contingencies arising from the matters discussed herein will have a material effect on the Company’s consolidated financial position or its ongoing results of operations or cash flows. However, in light of the inherent uncertainties noted above, an adverse outcome in one or more of these matters could be material to the Company’s results of operations or cash flows for any particular quarter or year. | ||
Brazilian Matters | ||
In 2001, the Central Bank of Brazil sought to impose a substantial fine on the Company’s Brazilian subsidiary based on alleged foreign exchange violations in connection with the financing of the Company’s 1995 acquisition of the Kolynos oral care business from Wyeth (formerly American Home Products) (the Seller), as described in the Company’s Form 8-K dated January 10, 1995. The Company appealed the imposition of the fine to the Brazilian Monetary System Appeals Council (the Council) and, on January 30, 2007, the Council decided the appeal in the Company’s favor, dismissing the fine entirely. However, certain tax and civil proceedings related to the same acquisition of the Kolynos oral care business are still outstanding as described below. | ||
The Brazilian internal revenue authority has disallowed interest deductions and foreign exchange losses taken by the Company’s Brazilian subsidiary for certain years in connection with the financing of the Kolynos acquisition. The tax assessments with interest, at the current exchange rate, are approximately $120. The Company has been disputing the disallowances by appealing the assessments within the internal revenue authority’s appellate process with the following results to date: | ||
▪ | In June 2005, the First Board of Taxpayers ruled in the Company’s favor and allowed all of the previously claimed deductions for 1996 through 1998. In March 2007, the First Board of Taxpayers ruled in the Company’s favor and allowed all of the previously claimed deductions for 1999 through 2001. The tax authorities appealed these decisions to the next administrative level. | |
▪ | In August 2009, the First Taxpayers’ Council (the next and final administrative level of appeal) overruled the decisions of the First Board of Taxpayers, upholding the majority of the assessments, disallowing a portion of the assessments and remanding a portion of the assessments for further consideration by the First Board of Taxpayers. | |
The Company has filed a motion for clarification with a special appeals chamber of the Taxpayers’ Council and further appeals are available within the Brazilian federal courts. The Company intends to challenge these assessments vigorously. Although there can be no assurances, management believes, based on the opinion of its Brazilian legal counsel and other advisors, that the disallowances are without merit and that the Company should ultimately prevail on appeal, if necessary, in the Brazilian federal courts. | ||
In 2002, the Brazilian Federal Public Attorney filed a civil action against the federal government of Brazil, Laboratorios Wyeth-Whitehall Ltda. (the Brazilian subsidiary of the Seller) and the Company, as represented by its Brazilian subsidiary, seeking to annul an April 2000 decision by the Brazilian Board of Tax Appeals that found in favor of the Seller’s Brazilian subsidiary on the issue of whether it had incurred taxable capital gains as a result of the divestiture of Kolynos. The action seeks to make the Company’s Brazilian subsidiary jointly and severally liable for any tax due from the Seller’s Brazilian subsidiary. Although there can be no assurances, management believes, based on the opinion of its Brazilian legal counsel, that the Company should ultimately prevail in this action. The Company intends to challenge this action vigorously. | ||
In December 2005, the Brazilian internal revenue authority issued to the Company’s Brazilian subsidiary a tax assessment with interest and penalties of approximately $75, at the current exchange rate, based on a claim that certain purchases of U.S. Treasury bills by the subsidiary and their subsequent disposition during the period 2000 to 2001 were subject to a tax on foreign exchange transactions. The Company is disputing the assessment within the internal revenue authority’s administrative appeals process. In October 2007, the Second Board of Taxpayers, which has jurisdiction over these matters, ruled in favor of the internal revenue authority. In January 2008, the Company appealed this decision, and in January 2012, a special appeals chamber of the Taxpayers’ Council denied the Company’s appeal. The Company has filed a motion for clarification with a special appeals chamber of the Taxpayers' Council and further appeals are available within the Brazilian federal courts. Although there can be no assurances, management believes, based on the advice of its Brazilian legal counsel, that the tax assessment is without merit and that the Company should prevail on appeal, if not at the administrative level, in the Brazilian federal courts. The Company intends to challenge this assessment vigorously. | ||
European Competition Matters | ||
Since February 2006, the Company has learned that investigations relating to potential competition law violations involving the Company’s subsidiaries had been commenced by governmental authorities in a number of European countries and by the European Commission. The Company understands that substantially all of these investigations also involve other consumer goods companies and/or retail customers. The status of the various pending matters is discussed below. | ||
Fines have been imposed on the Company in the following matters, although, as noted below, the Company has appealed each of these fines: | ||
▪ | In December 2009, the Swiss competition law authority imposed a fine of $6 on the Company’s GABA subsidiary for alleged violations of restrictions on parallel imports into Switzerland. The Company is appealing the fine in the Swiss courts. | |
▪ | In January 2010, Colgate’s Spanish subsidiary was fined $3 by the Spanish competition law authority on the basis that it had entered an agreement with other shower gel manufacturers regarding product downsizing, which the Company contested. The fine was annulled by the Court of Appeal in July 2013. The Spanish competition law authority is appealing this judgment before the Supreme Court. | |
▪ | In December 2010, the Italian competition law authority found that 16 consumer goods companies, including the Company’s Italian subsidiary, exchanged competitively sensitive information in the cosmetics sector, for which the Company’s Italian subsidiary was fined $3. The Company is appealing the fine in the Italian courts. | |
▪ | In December 2011, the French competition law authority found that four consumer goods companies had entered into agreements on pricing and promotion of heavy duty detergents for which Colgate’s French subsidiary was fined $46 in connection with a divested business. The Company is appealing the fine in the French courts. | |
▪ | In March 2012, the French competition law authority found that three pet food producers, including the Company’s Hill’s France subsidiary, had violated the competition law, for which it imposed a fine of $7 on the Company’s Hill’s France subsidiary for alleged restrictions on exports from France, which the Company contested. In October 2013, the Company’s appeal was denied. The Company is evaluating whether to pursue further appeals. | |
Currently, formal claims of violations, or statements of objections, are pending against the Company as follows: | ||
▪ | The Belgian competition law authority has alleged that 11 branded goods companies, including the Company’s Belgian subsidiary, assisted retailers to coordinate their retail prices on the Belgian market. The Company is in the process of responding to this statement of objections. | |
▪ | In the second quarter of 2013, the French competition law authority issued a statement of objections alleging that the Company's French subsidiary and a number of its competitors exchanged sensitive information related to the French home care and personal care sectors. The Company has responded to this statement of objections. | |
An investigation is ongoing in Greece, but no formal claim of violations has been filed. | ||
Since December 31, 2012, the following matter has been resolved: | ||
▪ | In March 2013, the German competition authority completed its investigation and no penalties were imposed against the Company or its German subsidiary. | |
The Company’s policy is to comply with antitrust and competition laws and, if a violation of any such laws is found, to take appropriate remedial action and to cooperate fully with any related governmental inquiry. The Company has undertaken a comprehensive review of its selling practices and related competition law compliance in Europe and elsewhere and, where the Company has identified a lack of compliance, it has undertaken remedial action. Competition and antitrust law investigations often continue for several years and can result in substantial fines for violations that are found. While the Company cannot predict the final financial impact of these competition law issues as these matters may change, the Company evaluates developments in these matters quarterly and accrues liabilities as and when appropriate. | ||
ERISA Matters | ||
In October 2007, a putative class action claiming that certain aspects of the cash balance portion of the Colgate-Palmolive Company Employees’ Retirement Income Plan (the Plan) do not comply with the Employee Retirement Income Security Act was filed against the Plan and the Company in the United States District Court for the Southern District of New York. Specifically, Proesel, et al. v. Colgate-Palmolive Company Employees’ Retirement Income Plan, et al. alleges improper calculation of lump sum distributions, age discrimination and failure to satisfy minimum accrual requirements, thereby resulting in the underpayment of benefits to Plan participants. | ||
Two other putative class actions filed earlier in 2007, Abelman, et al. v. Colgate-Palmolive Company Employees’ Retirement Income Plan, et al., in the United States District Court for the Southern District of Ohio, and Caufield v. Colgate-Palmolive Company Employees’ Retirement Income Plan, in the United States District Court for the Southern District of Indiana, both alleging improper calculation of lump sum distributions and, in the case of Abelman, claims for failure to satisfy minimum accrual requirements, were transferred to the Southern District of New York and consolidated with Proesel into one action, In re Colgate-Palmolive ERISA Litigation. The complaint in the consolidated action alleges improper calculation of lump sum distributions and failure to satisfy minimum accrual requirements, but does not include a claim for age discrimination. The relief sought includes recalculation of benefits in unspecified amounts, pre- and post-judgment interest, injunctive relief and attorneys’ fees. In October 2013, the parties executed a settlement agreement under which the Plan would pay approximately $40 after application of certain offsets to resolve the litigation. The settlement agreement is subject to court approval. On October 9, 2013, a motion for preliminary approval of a class action settlement, class certification and appointment of class counsel was filed. The Company and the Plan intend to contest this action vigorously should the settlement not be approved and finalized. |
Segment_Information
Segment Information | 9 Months Ended | |||||||||||||||
Sep. 30, 2013 | ||||||||||||||||
Notes to Financial Statements [Abstract] | ||||||||||||||||
Segment Information | Segment Information | |||||||||||||||
The Company has made certain changes in its segment reporting affecting several of the geographic operating segments within its Oral, Personal and Home Care product segment. These changes have no impact on the Company's historical consolidated financial position, results of operations or cash flows. | ||||||||||||||||
Effective January 1, 2013, the Company realigned the geographic structure of its North America and Latin America reportable operating segments. In order to better leverage Latin America management's knowledge of emerging market consumers to accelerate growth in the region, management responsibility for the Puerto Rico and CARICOM operations was transferred from North America to Latin America management. Accordingly, commencing with the Company's financial reporting for the quarter ended March 31, 2013, the results of the Puerto Rico and CARICOM operations, which represent less than 1% of the Company's global business, were reported in the Latin America reportable operating segment. Previously, Puerto Rico and CARICOM represented approximately 4% of Net sales of North America and now represent approximately 3% of Net sales of Latin America. | ||||||||||||||||
In addition, given the growing importance of the Company's operations in emerging markets, effective with the quarter ended September 30, 2013, the Company is separately reporting financial information for its Asia and Africa/Eurasia operating segments. Previously, the financial information for these operating segments was aggregated into the Greater Asia/Africa reportable operating segment. | ||||||||||||||||
The Company has recast its historical geographic segment information to conform to the new reporting structure which results in modification to the geographic components of the Oral, Personal and Home Care segment, with no impact on historical Company results overall. | ||||||||||||||||
The Company evaluates segment performance based on several factors, including Operating profit. The Company uses Operating profit as a measure of the operating segment performance because it excludes the impact of corporate-driven decisions related to interest expense and income taxes. Corporate operations include costs related to stock options and restricted stock awards, research and development costs, Corporate overhead costs, restructuring and related implementation costs and gains and losses on sales of non-core product lines and assets. The Company reports these items within Corporate operations as they relate to Corporate-based responsibilities and decisions and are not included in the internal measures of segment operating performance used by the Company in order to measure the underlying performance of the business segments. | ||||||||||||||||
Net sales and Operating profit by segment were as follows: | ||||||||||||||||
Three Months Ended | Nine Months Ended | |||||||||||||||
September 30, | September 30, | |||||||||||||||
2013 | 2012 | 2013 | 2012 | |||||||||||||
Net sales | ||||||||||||||||
Oral, Personal and Home Care | ||||||||||||||||
North America | $ | 774 | $ | 766 | $ | 2,300 | $ | 2,217 | ||||||||
Latin America | 1,251 | 1,276 | 3,747 | 3,777 | ||||||||||||
Europe/South Pacific | 880 | 865 | 2,552 | 2,569 | ||||||||||||
Asia | 627 | 583 | 1,900 | 1,717 | ||||||||||||
Africa/Eurasia | 321 | 314 | 932 | 918 | ||||||||||||
Total Oral, Personal and Home Care | 3,853 | 3,804 | 11,431 | 11,198 | ||||||||||||
Pet Nutrition | 545 | 528 | 1,628 | 1,601 | ||||||||||||
Total Net sales | $ | 4,398 | $ | 4,332 | $ | 13,059 | $ | 12,799 | ||||||||
Operating profit | ||||||||||||||||
Oral, Personal and Home Care | ||||||||||||||||
North America | $ | 244 | $ | 213 | $ | 686 | $ | 580 | ||||||||
Latin America | 358 | 377 | 1,022 | 1,100 | ||||||||||||
Europe/South Pacific | 216 | 198 | 605 | 560 | ||||||||||||
Asia | 174 | 164 | 533 | 474 | ||||||||||||
Africa/Eurasia | 65 | 67 | 192 | 197 | ||||||||||||
Total Oral, Personal and Home Care | 1,057 | 1,019 | 3,038 | 2,911 | ||||||||||||
Pet Nutrition | 138 | 147 | 410 | 440 | ||||||||||||
Corporate | (179 | ) | (139 | ) | (784 | ) | (404 | ) | ||||||||
Total Operating profit | $ | 1,016 | $ | 1,027 | $ | 2,664 | $ | 2,947 | ||||||||
Approximately 80% of the Company’s Net sales are generated from markets outside the U.S., with over 50% of the Company’s Net sales coming from emerging markets (which consist of Latin America, Asia (excluding Japan), Africa/Eurasia and Central Europe). | ||||||||||||||||
For the three months ended September 30, 2013, Corporate Operating profit (loss) includes costs of $30 associated with the 2012 Restructuring Program and costs of $3 related to the sale of land in Mexico. For the nine months ended September 30, 2013, Corporate Operating profit (loss) includes costs of $198 associated with 2012 Restructuring Program, a one-time $172 charge for the impact of the devaluation in Venezuela, a charge of $18 for a competition law matter in France related to the home care and personal care sectors and costs of $14 related to the sale of land in Mexico. For further information regarding the 2012 Restructuring Program, refer to Note 5, Restructuring and Related Implementation Charges. For further information regarding the Venezuela devaluation, refer to Note 15, Venezuela. For further information regarding the competition law matter in France, refer to Note 12, Contingencies. For further information regarding the sale of land in Mexico, refer to Note 4, Acquisitions and Divestitures. For the three months ended September 30, 2012, Corporate Operating profit (loss) included costs of $7 related to the sale of land in Mexico and costs of $3 associated with various business realignment and other cost-saving initiatives. For the nine months ended September 30, 2012, Corporate Operating profit (loss) included costs of $20 related to the sale of land in Mexico and costs of $21 associated with various business realignment and other cost-saving initiatives. |
Fair_Value_Measurements_and_Fi
Fair Value Measurements and Financial Instruments | 9 Months Ended | |||||||||||||||||||||||
Sep. 30, 2013 | ||||||||||||||||||||||||
Fair Value Measurements and Financial Instruments [Abstract] | ||||||||||||||||||||||||
Fair Value Measurements and Financial Instruments | Fair Value Measurements and Financial Instruments | |||||||||||||||||||||||
The Company uses available market information and other valuation methodologies in assessing the fair value of financial instruments. Judgment is required in interpreting market data to develop the estimates of fair value and, accordingly, changes in assumptions or the estimation methodologies may affect the fair value estimates. The Company is exposed to credit losses in the event of nonperformance by counterparties to financial instrument contracts; however, nonperformance is considered unlikely as it is the Company’s policy to contract only with diverse, credit-worthy counterparties based upon both strong credit ratings and other credit considerations. | ||||||||||||||||||||||||
The Company is exposed to market risk from foreign currency exchange rates, interest rates and commodity price fluctuations. Volatility relating to these exposures is managed on a global basis by utilizing a number of techniques, including working capital management, supplier agreements, selling price increases, selective borrowings in local currencies and entering into selective derivative instrument transactions, issued with standard features, in accordance with the Company’s treasury and risk management policies, which prohibit the use of derivatives for speculative purposes and leveraged derivatives for any purpose. It is the Company’s policy to enter into derivative instrument contracts with terms that match the underlying exposure being hedged. Hedge ineffectiveness, if any, is not material for any period presented. | ||||||||||||||||||||||||
The Company’s derivative instruments include interest rate swap contracts, foreign currency contracts and commodity contracts. The Company utilizes interest rate swap contracts to manage its targeted mix of fixed and floating rate debt, and these swaps are valued using observable benchmark rates (Level 2 valuation). Foreign currency contracts consist of forward, option and swap contracts utilized to hedge a portion of the Company’s foreign currency purchases, assets and liabilities arising in the normal course of business as well as the net investment in certain foreign subsidiaries. These contracts are valued using observable market rates (Level 2 valuation). Commodity futures contracts are utilized to hedge the purchases of raw materials used in the Company’s operations. These contracts are measured using quoted commodity exchange prices (Level 1 valuation). The duration of foreign currency and commodity contracts generally does not exceed twelve months. | ||||||||||||||||||||||||
The following summarizes the fair value of the Company’s derivative instruments and other financial instruments at September 30, 2013 and December 31, 2012: | ||||||||||||||||||||||||
Assets | Liabilities | |||||||||||||||||||||||
Fair Value | Account | Fair Value | ||||||||||||||||||||||
Account | ||||||||||||||||||||||||
Designated derivative instruments | 9/30/13 | 12/31/12 | 9/30/13 | 12/31/12 | ||||||||||||||||||||
Interest rate swap contracts | Other current assets | $ | 1 | $ | 3 | Other accruals | $ | — | $ | — | ||||||||||||||
Interest rate swap contracts | Other assets | 22 | 41 | Other liabilities | — | — | ||||||||||||||||||
Foreign currency contracts | Other current assets | 9 | 7 | Other accruals | 10 | 10 | ||||||||||||||||||
Foreign currency contracts | Other assets | 3 | 13 | Other liabilities | 1 | — | ||||||||||||||||||
Commodity contracts | Other current assets | — | 1 | Other accruals | — | — | ||||||||||||||||||
Total designated | $ | 35 | $ | 65 | $ | 11 | $ | 10 | ||||||||||||||||
Derivatives not designated | ||||||||||||||||||||||||
Foreign currency contracts | Other current assets | $ | — | $ | — | Other accruals | $ | 1 | $ | 1 | ||||||||||||||
Total not designated | $ | — | $ | — | $ | 1 | $ | 1 | ||||||||||||||||
Total derivative instruments | $ | 35 | $ | 65 | $ | 12 | $ | 11 | ||||||||||||||||
Other financial instruments | ||||||||||||||||||||||||
Marketable securities | Other current assets | $ | 146 | $ | 116 | |||||||||||||||||||
Available-for-sale securities | Other assets | 676 | 618 | |||||||||||||||||||||
Total other financial instruments | $ | 822 | $ | 734 | ||||||||||||||||||||
The carrying amount of cash, cash equivalents, accounts receivable and short-term debt approximated fair value as of September 30, 2013 and December 31, 2012. The estimated fair value of the Company’s long-term debt, including the current portion, as of September 30, 2013 and December 31, 2012, was $5,465 and $5,484, respectively, and the related carrying value was $5,265 and $5,176, respectively. The estimated fair value of long-term debt was derived principally from quoted prices on the Company’s outstanding fixed-term notes (Level 2 valuation). | ||||||||||||||||||||||||
Fair value hedges | ||||||||||||||||||||||||
The Company has designated all interest rate swap contracts and certain foreign currency forward and option contracts as fair value hedges, for which the gain or loss on the derivative and the offsetting loss or gain on the hedged item are recognized in current earnings. The impact of foreign currency contracts is recognized in Selling, general and administrative expenses and the impact of interest rate swap contracts is recognized in Interest expense, net. | ||||||||||||||||||||||||
Activity related to fair value hedges recorded during the three-month and nine-month periods ended September 30, 2013 and 2012 was as follows: | ||||||||||||||||||||||||
2013 | 2012 | |||||||||||||||||||||||
Foreign | Interest | Foreign | Interest | |||||||||||||||||||||
Currency | Rate | Total | Currency | Rate | Total | |||||||||||||||||||
Contracts | Swaps | Contracts | Swaps | |||||||||||||||||||||
Notional Value at September 30, | $ | 1,568 | $ | 1,088 | $ | 2,656 | $ | 944 | $ | 1,338 | $ | 2,282 | ||||||||||||
Three months ended September 30: | ||||||||||||||||||||||||
Gain (loss) on derivative | (9 | ) | 2 | (7 | ) | (8 | ) | 5 | (3 | ) | ||||||||||||||
Gain (loss) on hedged items | 9 | (2 | ) | 7 | 8 | (5 | ) | 3 | ||||||||||||||||
Nine months ended September 30: | ||||||||||||||||||||||||
Gain (loss) on derivative | 3 | (18 | ) | (15 | ) | 2 | 12 | 14 | ||||||||||||||||
Gain (loss) on hedged items | (3 | ) | 18 | 15 | (2 | ) | (12 | ) | (14 | ) | ||||||||||||||
Cash flow hedges | ||||||||||||||||||||||||
All of the Company’s commodity contracts and certain foreign currency forward contracts have been designated as cash flow hedges, for which the effective portion of the gain or loss is reported as a component of Other comprehensive income (OCI) and reclassified into earnings in the same period or periods during which the hedged transaction affects earnings. | ||||||||||||||||||||||||
Activity related to cash flow hedges recorded during the three-month and nine-month periods ended September 30, 2013 and 2012 was as follows: | ||||||||||||||||||||||||
2013 | 2012 | |||||||||||||||||||||||
Foreign | Commodity | Foreign | Commodity | |||||||||||||||||||||
Currency | Contracts | Total | Currency | Contracts | Total | |||||||||||||||||||
Contracts | Contracts | |||||||||||||||||||||||
Notional Value at September 30, | $ | 441 | $ | 15 | $ | 456 | $ | 347 | $ | 26 | $ | 373 | ||||||||||||
Three months ended September 30: | ||||||||||||||||||||||||
Gain (loss) recognized in OCI | 2 | — | 2 | (7 | ) | 6 | (1 | ) | ||||||||||||||||
Gain (loss) reclassified into Cost of sales | 8 | — | 8 | (1 | ) | 4 | 3 | |||||||||||||||||
Nine months ended September 30: | ||||||||||||||||||||||||
Gain (loss) recognized in OCI | 13 | — | 13 | (4 | ) | 11 | 7 | |||||||||||||||||
Gain (loss) reclassified into Cost of sales | 12 | 1 | 13 | — | 4 | 4 | ||||||||||||||||||
The net gain (loss) recognized in OCI for both foreign currency contracts and commodity contracts is expected to be recognized in Cost of sales within the next twelve months. | ||||||||||||||||||||||||
Net investment hedges | ||||||||||||||||||||||||
The Company has designated certain foreign currency forward contracts, option contracts and foreign currency-denominated debt as net investment hedges, for which the gain or loss on the instrument is reported as a component of Currency translation adjustments within OCI, along with the offsetting gain or loss on the hedged items. | ||||||||||||||||||||||||
Activity related to net investment hedges recorded during the three-month and nine-month periods ended September 30, 2013 and 2012 was as follows: | ||||||||||||||||||||||||
2013 | 2012 | |||||||||||||||||||||||
Foreign | Foreign | Foreign | Foreign | |||||||||||||||||||||
Currency | Currency | Total | Currency | Currency | Total | |||||||||||||||||||
Contracts | Debt | Contracts | Debt | |||||||||||||||||||||
Notional Value at September 30, | $ | 557 | $ | 238 | $ | 795 | $ | 527 | $ | 296 | $ | 823 | ||||||||||||
Three months ended September 30: | ||||||||||||||||||||||||
Gain (loss) on instruments | (18 | ) | (9 | ) | (27 | ) | (6 | ) | (2 | ) | (8 | ) | ||||||||||||
Gain (loss) on hedged items | 18 | 9 | 27 | 8 | 2 | 10 | ||||||||||||||||||
Nine months ended September 30: | ||||||||||||||||||||||||
Gain (loss) on instruments | (8 | ) | — | (8 | ) | 2 | 2 | 4 | ||||||||||||||||
Gain (loss) on hedged items | 9 | — | 9 | (5 | ) | (2 | ) | (7 | ) | |||||||||||||||
Derivatives Not Designated as Hedging Instruments | ||||||||||||||||||||||||
Derivatives not designated as hedging instruments for each period consist of a cross-currency swap that serves as an economic hedge of a foreign currency deposit, for which the gain or loss on the instrument and the offsetting gain or loss on the hedged item are recognized in Other (income) expense, net for each period. | ||||||||||||||||||||||||
Activity related to these contracts during the three-month and nine-month periods ended September 30, 2013 and 2012 was as follows: | ||||||||||||||||||||||||
2013 | 2012 | |||||||||||||||||||||||
Cross-currency | Cross-currency | |||||||||||||||||||||||
Swap | Swap | |||||||||||||||||||||||
Notional Value at September 30, | $ | 96 | $ | 96 | ||||||||||||||||||||
Three months ended September 30: | ||||||||||||||||||||||||
Gain (loss) on instrument | (6 | ) | (3 | ) | ||||||||||||||||||||
Gain (loss) on hedged item | 6 | 3 | ||||||||||||||||||||||
Nine months ended September 30: | ||||||||||||||||||||||||
Gain (loss) on instrument | — | (4 | ) | |||||||||||||||||||||
Gain (loss) on hedged item | — | 4 | ||||||||||||||||||||||
Other Financial Instruments | ||||||||||||||||||||||||
Other financial instruments are classified as Other current assets or Other assets. | ||||||||||||||||||||||||
Other financial instruments classified as Other current assets include marketable securities, which consist of bank deposits of $122 with original maturities greater than 90 days (Level 1 valuation) and the current portion of bonds issued by the Venezuelan government (Level 2 valuation) in the amount of $24. The long-term portion of these bonds in the amount of $676 is included in Other assets. | ||||||||||||||||||||||||
Through its subsidiary in Venezuela, the Company is invested in U.S. dollar-linked, devaluation-protected bonds and fixed interest rate bonds, both of which are issued by the Venezuelan government. These bonds are actively traded and, therefore, are considered Level 2 investments as their values are determined based upon observable market-based inputs or unobservable inputs that are corroborated by market data. As of September 30, 2013, the U.S. dollar-linked, devaluation protected bonds and the fixed interest rate bonds had fair market values of $257 and $443, respectively. These investments are considered available-for-sale securities and, as noted above, $24 is included in Other current assets and $676 is included in Other assets. | ||||||||||||||||||||||||
The following table presents a reconciliation of the fair value of the Venezuelan bonds for the nine months ended September 30, 2013 and 2012: | ||||||||||||||||||||||||
2013 | 2012 | |||||||||||||||||||||||
Beginning balance as of January 1, | $ | 642 | $ | 236 | ||||||||||||||||||||
Unrealized gain (loss) on investment | (124 | ) | 14 | |||||||||||||||||||||
Purchases and sales during the period | 182 | 373 | ||||||||||||||||||||||
Ending balance as of September 30, | $ | 700 | $ | 623 | ||||||||||||||||||||
The Unrealized loss on investment consisted primarily of a one-time loss of $133 in the first quarter of 2013 related to the remeasurement of the fixed interest rate bonds at February 9, 2013, the date of the devaluation. For further information regarding Venezuela and the devaluation, refer to Note 15, Venezuela below. |
Venezuela
Venezuela | 9 Months Ended |
Sep. 30, 2013 | |
Notes to Financial Statements [Abstract] | |
Venezuela | Venezuela |
Venezuela has been designated hyper-inflationary and, therefore, the functional currency for the Company’s Venezuelan subsidiary (“CP Venezuela”) is the U.S. dollar and Venezuelan currency fluctuations are reported in income. | |
The Venezuelan government devalued its currency effective February 9, 2013. As a result of the devaluation the official exchange rate changed from 4.30 to 6.30 Venezuela bolivares fuerte per dollar. The Company incurred a one-time, pretax loss of $172 ($111 aftertax loss) in the first quarter of 2013 related to the remeasurement of the net monetary assets included in the local balance sheet at the date of the devaluation. The impact of this one-time aftertax loss of $111 on diluted earnings per common share was $0.12 for the nine months ended September 30, 2013. The Company remeasured the financial statements of CP Venezuela at the rate at which it currently expects to remit future dividends, which is 6.30. As the local currency operations in Venezuela translated into fewer U.S. dollars, this had and will continue to have an ongoing adverse effect on the Company's reported results. | |
For the nine months ended September 30, 2013, CP Venezuela represented approximately 4% of the Company’s consolidated Net sales. At September 30, 2013, CP Venezuela’s bolivar fuerte-denominated net monetary asset position, which would be subject to remeasurement in the event of a further devaluation, was approximately $530. This amount does not include $257 of devaluation-protected bonds issued by the Venezuelan government, as these bonds provide protection against devaluations by adjusting the amount of bolivares fuerte received at maturity for any devaluation subsequent to issuance. |
Restructuring_and_Related_Impl1
Restructuring and Related Implementation Charges (Tables) | 9 Months Ended | ||||||||||||||||||||
Sep. 30, 2013 | |||||||||||||||||||||
Restructuring and Related Activities [Abstract] | |||||||||||||||||||||
Schedule of Restructuring and Related Costs | For the three and nine months ended September 30, 2013, restructuring and implementation-related charges are reflected in the income statement as follows: | ||||||||||||||||||||
Three Months Ended | Nine Months Ended | ||||||||||||||||||||
30-Sep-13 | 30-Sep-13 | ||||||||||||||||||||
Cost of sales | $ | 8 | $ | 26 | |||||||||||||||||
Selling, general and administrative expenses | 9 | 31 | |||||||||||||||||||
Other (income) expense, net | 13 | 141 | |||||||||||||||||||
Total 2012 Restructuring Program charges, pretax | $ | 30 | $ | 198 | |||||||||||||||||
Total 2012 Restructuring Program charges, aftertax | $ | 22 | $ | 153 | |||||||||||||||||
Schedule of Restructuring and Related Costs Incurred to Date | Since the inception of the 2012 Restructuring Program in the fourth quarter of 2012, the Company has incurred pretax cumulative charges of $287 ($223 aftertax) in connection with the implementation of various projects as follows: | ||||||||||||||||||||
Cumulative Charges | |||||||||||||||||||||
as of September 30, 2013 | |||||||||||||||||||||
Employee-Related Costs | $ | 169 | |||||||||||||||||||
Incremental Depreciation | 20 | ||||||||||||||||||||
Asset Impairments | 1 | ||||||||||||||||||||
Other | 97 | ||||||||||||||||||||
Total | $ | 287 | |||||||||||||||||||
Schedule of Restructuring Reserve by Type of Cost | The following tables summarize the activity for the restructuring and implementation-related charges discussed above and the related accrual: | ||||||||||||||||||||
Three Months Ended September 30, 2013 | |||||||||||||||||||||
Employee-Related | Incremental | Asset | Other | Total | |||||||||||||||||
Costs | Depreciation | Impairments | |||||||||||||||||||
Balance at June 30, 2013 | $ | 141 | $ | — | $ | — | $ | 31 | $ | 172 | |||||||||||
Charges | 5 | 5 | — | 20 | 30 | ||||||||||||||||
Cash payments | (40 | ) | — | — | (11 | ) | (51 | ) | |||||||||||||
Charges against assets | — | (5 | ) | — | — | (5 | ) | ||||||||||||||
Foreign exchange | — | — | — | — | — | ||||||||||||||||
Balance at September 30, 2013 | $ | 106 | $ | — | $ | — | $ | 40 | $ | 146 | |||||||||||
Nine Months Ended September 30, 2013 | |||||||||||||||||||||
Employee-Related | Incremental | Asset | Other | Total | |||||||||||||||||
Costs | Depreciation | Impairments | |||||||||||||||||||
Balance at December 31, 2012 | $ | 84 | $ | — | $ | — | $ | 5 | $ | 89 | |||||||||||
Charges | 91 | 20 | 1 | 86 | 198 | ||||||||||||||||
Cash payments | (52 | ) | — | — | (51 | ) | (103 | ) | |||||||||||||
Charges against assets | (17 | ) | (20 | ) | (1 | ) | — | (38 | ) | ||||||||||||
Foreign exchange | — | — | — | — | — | ||||||||||||||||
Balance at September 30, 2013 | $ | 106 | $ | — | $ | — | $ | 40 | $ | 146 | |||||||||||
Inventories_Tables
Inventories (Tables) | 9 Months Ended | |||||||
Sep. 30, 2013 | ||||||||
Inventory, Net [Abstract] | ||||||||
Inventories By Major Class | Inventories by major class are as follows: | |||||||
September 30, | December 31, | |||||||
2013 | 2012 | |||||||
Raw materials and supplies | $ | 340 | $ | 362 | ||||
Work-in-process | 58 | 81 | ||||||
Finished goods | 1,043 | 922 | ||||||
Total Inventories | $ | 1,441 | $ | 1,365 | ||||
Shareholders_Equity_Tables
Shareholders' Equity (Tables) | 9 Months Ended | |||||||||||||||||||||||||||
Sep. 30, 2013 | ||||||||||||||||||||||||||||
Notes to Financial Statements [Abstract] | ||||||||||||||||||||||||||||
Shareholders' Equity | Changes in the components of Shareholders’ Equity for the nine months ended September 30, 2013 are as follows: | |||||||||||||||||||||||||||
Colgate-Palmolive Company Shareholders’ Equity | Noncontrolling | |||||||||||||||||||||||||||
Interests | ||||||||||||||||||||||||||||
Common | Additional | Unearned | Treasury | Retained | Accumulated | |||||||||||||||||||||||
Stock | Paid-in | Compensation | Stock | Earnings | Other | |||||||||||||||||||||||
Capital | Comprehensive | |||||||||||||||||||||||||||
Income (Loss) | ||||||||||||||||||||||||||||
Balance, December 31, 2012 | $ | 1,466 | $ | 818 | $ | (41 | ) | $ | (14,386 | ) | $ | 16,953 | $ | (2,621 | ) | $ | 201 | |||||||||||
Net income | 1,677 | 132 | ||||||||||||||||||||||||||
Other comprehensive income, net of tax | (95 | ) | (7 | ) | ||||||||||||||||||||||||
Dividends | (1,237 | ) | (108 | ) | ||||||||||||||||||||||||
Stock-based compensation expense | 105 | |||||||||||||||||||||||||||
Shares issued for stock options | 64 | 195 | ||||||||||||||||||||||||||
Shares issued for restricted stock awards | (72 | ) | 72 | |||||||||||||||||||||||||
Treasury stock acquired | (1,115 | ) | ||||||||||||||||||||||||||
Other | (3 | ) | 6 | (2 | ) | 5 | ||||||||||||||||||||||
Balance, September 30, 2013 | $ | 1,466 | $ | 912 | $ | (35 | ) | $ | (15,236 | ) | $ | 17,393 | $ | (2,716 | ) | $ | 223 | |||||||||||
Accumulated other comprehensive income (loss) includes cumulative foreign currency translation losses of $1,767 and $1,609 at September 30, 2013 and December 31, 2012, respectively, and unrecognized pension and other retiree benefit costs of $997 and $1,053 at September 30, 2013 and December 31, 2012, respectively. |
Earnings_Per_Share_Tables
Earnings Per Share (Tables) | 9 Months Ended | |||||||||||||||||||||
Sep. 30, 2013 | ||||||||||||||||||||||
Earnings Per Share [Abstract] | ||||||||||||||||||||||
Schedule of Earnings Per Share, Basic and Diluted | ||||||||||||||||||||||
Three Months Ended | ||||||||||||||||||||||
September 30, 2013 | September 30, 2012 | |||||||||||||||||||||
Net income attributable to Colgate-Palmolive Company | Shares | Per | Net income attributable to Colgate-Palmolive Company | Shares | Per | |||||||||||||||||
(millions) | Share | (millions) | Share | |||||||||||||||||||
Basic EPS | $ | 656 | 928.1 | $ | 0.71 | $ | 654 | 949.8 | $ | 0.69 | ||||||||||||
Stock options and | 8.8 | 8.6 | ||||||||||||||||||||
restricted stock | ||||||||||||||||||||||
Diluted EPS | $ | 656 | 936.9 | $ | 0.7 | $ | 654 | 958.4 | $ | 0.68 | ||||||||||||
For the three months ended September 30, 2013 and 2012, the average number of stock options and restricted stock awards that were anti-dilutive and not included in diluted earnings per share calculations were 1,956,750 and 1,214,526, respectively. | ||||||||||||||||||||||
Nine Months Ended | ||||||||||||||||||||||
September 30, 2013 | September 30, 2012 | |||||||||||||||||||||
Net income attributable to Colgate-Palmolive Company | Shares | Per | Net income attributable to Colgate-Palmolive Company | Shares | Per | |||||||||||||||||
(millions) | Share | (millions) | Share | |||||||||||||||||||
Basic EPS | $ | 1,677 | 932.5 | $ | 1.8 | $ | 1,874 | 954.8 | $ | 1.96 | ||||||||||||
Stock options and | 8.9 | 8.1 | ||||||||||||||||||||
restricted stock | ||||||||||||||||||||||
Diluted EPS | $ | 1,677 | 941.4 | $ | 1.78 | $ | 1,874 | 962.9 | $ | 1.95 | ||||||||||||
For the nine months ended September 30, 2013 and 2012, the average number of stock options and restricted stock awards that were anti-dilutive and not included in diluted earnings per share calculations were 703,219 and 1,259,888, respectively. |
Other_Comprehensive_Income_Tab
Other Comprehensive Income (Tables) | 9 Months Ended | ||||||||||||||
Sep. 30, 2013 | |||||||||||||||
Other Comprehensive Income (Loss) [Abstract] | |||||||||||||||
Schedule of Comprehensive Income (Loss) | Additions to and reclassifications out of Accumulated other comprehensive income (loss) attributable to the Company for the three months ended September 30, 2013 and 2012 were as follows: | ||||||||||||||
2013 | 2012 | ||||||||||||||
Pre-tax | Net of Tax | Pre-tax | Net of Tax | ||||||||||||
Cumulative translation adjustments | $ | 82 | $ | 93 | $ | 79 | $ | 81 | |||||||
Pension and other benefits: | |||||||||||||||
Net actuarial gains (losses) and prior service costs arising during the period | 1 | 1 | 13 | 8 | |||||||||||
Amortization of net actuarial losses, transition and prior service costs (1) | 27 | 17 | 27 | 17 | |||||||||||
Retirement Plan and other retiree benefit adjustments | 28 | 18 | 40 | 25 | |||||||||||
Available-for-sale securities: | |||||||||||||||
Unrealized gains (losses) on available-for-sale securities | 4 | 3 | (8 | ) | (5 | ) | |||||||||
Reclassification of (gains) losses into net earnings on available-for-sale securities | — | — | — | — | |||||||||||
Gains (losses) on available-for-sale securities | 4 | 3 | (8 | ) | (5 | ) | |||||||||
Cash flow hedges: | |||||||||||||||
Unrealized gains (losses) on cash flow hedges | 2 | — | (1 | ) | — | ||||||||||
Reclassification of (gains) losses into net earnings on cash flow hedges (2) | (8 | ) | (5 | ) | (3 | ) | (2 | ) | |||||||
Gains (losses) on cash flow hedges | (6 | ) | (5 | ) | (4 | ) | (2 | ) | |||||||
Total Other comprehensive income (loss) | $ | 108 | $ | 109 | $ | 107 | $ | 99 | |||||||
(1)These components of Other comprehensive income (loss) are included in the computation of net periodic benefit cost. See Note 11, Retirement Plans and Other Retiree Benefits for additional details. | |||||||||||||||
(2)These (gains) losses are reclassified into Cost of sales. See Note 14, Fair Value Measurements and Financial Instruments for additional details. | |||||||||||||||
Additions to and reclassifications out of Accumulated other comprehensive income (loss) attributable to the Company for the nine months ended September 30, 2013 and 2012 were as follows: | |||||||||||||||
2013 | 2012 | ||||||||||||||
Pre-tax | Net of Tax | Pre-tax | Net of Tax | ||||||||||||
Cumulative translation adjustments | $ | (170 | ) | $ | (158 | ) | $ | (26 | ) | $ | (27 | ) | |||
Pension and other benefits: | |||||||||||||||
Net actuarial gains (losses) and prior service costs arising during the period | 4 | 3 | (19 | ) | (14 | ) | |||||||||
Amortization of net actuarial losses, transition and prior service costs (1) | 82 | 53 | 76 | 49 | |||||||||||
Retirement Plan and other retiree benefit adjustments | 86 | 56 | 57 | 35 | |||||||||||
Available-for-sale securities: | |||||||||||||||
Unrealized gains (losses) on available-for-sale securities | (124 | ) | (79 | ) | 14 | 9 | |||||||||
Reclassification of (gains) losses into net earnings on available-for-sale securities (2) | 133 | 86 | — | — | |||||||||||
Gains (losses) on available-for-sale securities | 9 | 7 | 14 | 9 | |||||||||||
Cash flow hedges: | |||||||||||||||
Unrealized gains (losses) on cash flow hedges | 13 | 8 | 7 | 5 | |||||||||||
Reclassification of (gains) losses into net earnings on cash flow hedges (3) | (13 | ) | (8 | ) | (4 | ) | (2 | ) | |||||||
Gains (losses) on cash flow hedges | — | — | 3 | 3 | |||||||||||
Total Other comprehensive income (loss) | $ | (75 | ) | $ | (95 | ) | $ | 48 | $ | 20 | |||||
(1)These components of Other comprehensive income (loss) are included in the computation of net periodic benefit cost. See Note 11, Retirement Plans and Other Retiree Benefits for additional details. | |||||||||||||||
(2)Represents the one-time loss related to the remeasurement of the fixed interest rate bonds in Venezuela which was recorded in Other (income) expense, net. See Note 14, Fair Value Measurements and Financial Instruments for additional details. | |||||||||||||||
(3)These (gains) losses are reclassified into Cost of sales. See Note 14, Fair Value Measurements and Financial Instruments for additional details. |
Retirement_Plans_and_Other_Ret1
Retirement Plans and Other Retiree Benefits (Tables) | 9 Months Ended | |||||||||||||||||||||||
Sep. 30, 2013 | ||||||||||||||||||||||||
Notes to Financial Statements [Abstract] | ||||||||||||||||||||||||
Components Of Net Periodic Benefit Cost | Components of Net periodic benefit cost for the three-month and nine-month periods ended September 30, 2013 and 2012 were as follows: | |||||||||||||||||||||||
Pension Benefits | Other Retiree Benefits | |||||||||||||||||||||||
United States | International | |||||||||||||||||||||||
Three Months Ended September 30, | ||||||||||||||||||||||||
2013 | 2012 | 2013 | 2012 | 2013 | 2012 | |||||||||||||||||||
Service cost | $ | 6 | $ | 4 | $ | 6 | $ | 6 | $ | 3 | $ | 2 | ||||||||||||
Interest cost | 22 | 24 | 8 | 9 | 8 | 9 | ||||||||||||||||||
ESOP offset | — | — | — | — | — | — | ||||||||||||||||||
Expected return on plan assets | (29 | ) | (28 | ) | (7 | ) | (7 | ) | (1 | ) | (1 | ) | ||||||||||||
Amortization of transition and prior service costs (credits) | 1 | 2 | 1 | 1 | — | — | ||||||||||||||||||
Amortization of actuarial loss | 17 | 17 | 3 | 2 | 5 | 5 | ||||||||||||||||||
Net periodic benefit cost | $ | 17 | $ | 19 | $ | 11 | $ | 11 | $ | 15 | $ | 15 | ||||||||||||
Pension Benefits | Other Retiree Benefits | |||||||||||||||||||||||
United States | International | |||||||||||||||||||||||
Nine Months Ended September 30, | ||||||||||||||||||||||||
2013 | 2012 | 2013 | 2012 | 2013 | 2012 | |||||||||||||||||||
Service cost | $ | 20 | $ | 18 | $ | 16 | $ | 17 | $ | 10 | $ | 8 | ||||||||||||
Interest cost | 68 | 73 | 22 | 26 | 28 | 30 | ||||||||||||||||||
ESOP offset | — | — | — | — | (1 | ) | (1 | ) | ||||||||||||||||
Expected return on plan assets | (88 | ) | (84 | ) | (19 | ) | (19 | ) | (2 | ) | (2 | ) | ||||||||||||
Amortization of transition and prior service costs (credits) | 6 | 7 | 1 | 1 | — | 2 | ||||||||||||||||||
Amortization of actuarial loss | 49 | 46 | 10 | 7 | 16 | 13 | ||||||||||||||||||
Net periodic benefit cost | $ | 55 | $ | 60 | $ | 30 | $ | 32 | $ | 51 | $ | 50 | ||||||||||||
Segment_Information_Tables
Segment Information (Tables) | 9 Months Ended | |||||||||||||||
Sep. 30, 2013 | ||||||||||||||||
Notes to Financial Statements [Abstract] | ||||||||||||||||
Net Sales and Operating Profit by Segment | Net sales and Operating profit by segment were as follows: | |||||||||||||||
Three Months Ended | Nine Months Ended | |||||||||||||||
September 30, | September 30, | |||||||||||||||
2013 | 2012 | 2013 | 2012 | |||||||||||||
Net sales | ||||||||||||||||
Oral, Personal and Home Care | ||||||||||||||||
North America | $ | 774 | $ | 766 | $ | 2,300 | $ | 2,217 | ||||||||
Latin America | 1,251 | 1,276 | 3,747 | 3,777 | ||||||||||||
Europe/South Pacific | 880 | 865 | 2,552 | 2,569 | ||||||||||||
Asia | 627 | 583 | 1,900 | 1,717 | ||||||||||||
Africa/Eurasia | 321 | 314 | 932 | 918 | ||||||||||||
Total Oral, Personal and Home Care | 3,853 | 3,804 | 11,431 | 11,198 | ||||||||||||
Pet Nutrition | 545 | 528 | 1,628 | 1,601 | ||||||||||||
Total Net sales | $ | 4,398 | $ | 4,332 | $ | 13,059 | $ | 12,799 | ||||||||
Operating profit | ||||||||||||||||
Oral, Personal and Home Care | ||||||||||||||||
North America | $ | 244 | $ | 213 | $ | 686 | $ | 580 | ||||||||
Latin America | 358 | 377 | 1,022 | 1,100 | ||||||||||||
Europe/South Pacific | 216 | 198 | 605 | 560 | ||||||||||||
Asia | 174 | 164 | 533 | 474 | ||||||||||||
Africa/Eurasia | 65 | 67 | 192 | 197 | ||||||||||||
Total Oral, Personal and Home Care | 1,057 | 1,019 | 3,038 | 2,911 | ||||||||||||
Pet Nutrition | 138 | 147 | 410 | 440 | ||||||||||||
Corporate | (179 | ) | (139 | ) | (784 | ) | (404 | ) | ||||||||
Total Operating profit | $ | 1,016 | $ | 1,027 | $ | 2,664 | $ | 2,947 | ||||||||
Fair_Value_Measurements_and_Fi1
Fair Value Measurements and Financial Instruments (Tables) | 9 Months Ended | |||||||||||||||||||||||
Sep. 30, 2013 | ||||||||||||||||||||||||
Notes to Financial Statements [Abstract] | ||||||||||||||||||||||||
Schedule of derivative instruments | The following summarizes the fair value of the Company’s derivative instruments and other financial instruments at September 30, 2013 and December 31, 2012: | |||||||||||||||||||||||
Assets | Liabilities | |||||||||||||||||||||||
Fair Value | Account | Fair Value | ||||||||||||||||||||||
Account | ||||||||||||||||||||||||
Designated derivative instruments | 9/30/13 | 12/31/12 | 9/30/13 | 12/31/12 | ||||||||||||||||||||
Interest rate swap contracts | Other current assets | $ | 1 | $ | 3 | Other accruals | $ | — | $ | — | ||||||||||||||
Interest rate swap contracts | Other assets | 22 | 41 | Other liabilities | — | — | ||||||||||||||||||
Foreign currency contracts | Other current assets | 9 | 7 | Other accruals | 10 | 10 | ||||||||||||||||||
Foreign currency contracts | Other assets | 3 | 13 | Other liabilities | 1 | — | ||||||||||||||||||
Commodity contracts | Other current assets | — | 1 | Other accruals | — | — | ||||||||||||||||||
Total designated | $ | 35 | $ | 65 | $ | 11 | $ | 10 | ||||||||||||||||
Derivatives not designated | ||||||||||||||||||||||||
Foreign currency contracts | Other current assets | $ | — | $ | — | Other accruals | $ | 1 | $ | 1 | ||||||||||||||
Total not designated | $ | — | $ | — | $ | 1 | $ | 1 | ||||||||||||||||
Total derivative instruments | $ | 35 | $ | 65 | $ | 12 | $ | 11 | ||||||||||||||||
Other financial instruments | ||||||||||||||||||||||||
Marketable securities | Other current assets | $ | 146 | $ | 116 | |||||||||||||||||||
Available-for-sale securities | Other assets | 676 | 618 | |||||||||||||||||||||
Total other financial instruments | $ | 822 | $ | 734 | ||||||||||||||||||||
Activity related to fair value hedges | Activity related to fair value hedges recorded during the three-month and nine-month periods ended September 30, 2013 and 2012 was as follows: | |||||||||||||||||||||||
2013 | 2012 | |||||||||||||||||||||||
Foreign | Interest | Foreign | Interest | |||||||||||||||||||||
Currency | Rate | Total | Currency | Rate | Total | |||||||||||||||||||
Contracts | Swaps | Contracts | Swaps | |||||||||||||||||||||
Notional Value at September 30, | $ | 1,568 | $ | 1,088 | $ | 2,656 | $ | 944 | $ | 1,338 | $ | 2,282 | ||||||||||||
Three months ended September 30: | ||||||||||||||||||||||||
Gain (loss) on derivative | (9 | ) | 2 | (7 | ) | (8 | ) | 5 | (3 | ) | ||||||||||||||
Gain (loss) on hedged items | 9 | (2 | ) | 7 | 8 | (5 | ) | 3 | ||||||||||||||||
Nine months ended September 30: | ||||||||||||||||||||||||
Gain (loss) on derivative | 3 | (18 | ) | (15 | ) | 2 | 12 | 14 | ||||||||||||||||
Gain (loss) on hedged items | (3 | ) | 18 | 15 | (2 | ) | (12 | ) | (14 | ) | ||||||||||||||
Activity related to cash flow hedges | Activity related to cash flow hedges recorded during the three-month and nine-month periods ended September 30, 2013 and 2012 was as follows: | |||||||||||||||||||||||
2013 | 2012 | |||||||||||||||||||||||
Foreign | Commodity | Foreign | Commodity | |||||||||||||||||||||
Currency | Contracts | Total | Currency | Contracts | Total | |||||||||||||||||||
Contracts | Contracts | |||||||||||||||||||||||
Notional Value at September 30, | $ | 441 | $ | 15 | $ | 456 | $ | 347 | $ | 26 | $ | 373 | ||||||||||||
Three months ended September 30: | ||||||||||||||||||||||||
Gain (loss) recognized in OCI | 2 | — | 2 | (7 | ) | 6 | (1 | ) | ||||||||||||||||
Gain (loss) reclassified into Cost of sales | 8 | — | 8 | (1 | ) | 4 | 3 | |||||||||||||||||
Nine months ended September 30: | ||||||||||||||||||||||||
Gain (loss) recognized in OCI | 13 | — | 13 | (4 | ) | 11 | 7 | |||||||||||||||||
Gain (loss) reclassified into Cost of sales | 12 | 1 | 13 | — | 4 | 4 | ||||||||||||||||||
Activity related to net investment hedges | Activity related to net investment hedges recorded during the three-month and nine-month periods ended September 30, 2013 and 2012 was as follows: | |||||||||||||||||||||||
2013 | 2012 | |||||||||||||||||||||||
Foreign | Foreign | Foreign | Foreign | |||||||||||||||||||||
Currency | Currency | Total | Currency | Currency | Total | |||||||||||||||||||
Contracts | Debt | Contracts | Debt | |||||||||||||||||||||
Notional Value at September 30, | $ | 557 | $ | 238 | $ | 795 | $ | 527 | $ | 296 | $ | 823 | ||||||||||||
Three months ended September 30: | ||||||||||||||||||||||||
Gain (loss) on instruments | (18 | ) | (9 | ) | (27 | ) | (6 | ) | (2 | ) | (8 | ) | ||||||||||||
Gain (loss) on hedged items | 18 | 9 | 27 | 8 | 2 | 10 | ||||||||||||||||||
Nine months ended September 30: | ||||||||||||||||||||||||
Gain (loss) on instruments | (8 | ) | — | (8 | ) | 2 | 2 | 4 | ||||||||||||||||
Gain (loss) on hedged items | 9 | — | 9 | (5 | ) | (2 | ) | (7 | ) | |||||||||||||||
Activity related to derivatives not designated as hedging instruments | Activity related to these contracts during the three-month and nine-month periods ended September 30, 2013 and 2012 was as follows: | |||||||||||||||||||||||
2013 | 2012 | |||||||||||||||||||||||
Cross-currency | Cross-currency | |||||||||||||||||||||||
Swap | Swap | |||||||||||||||||||||||
Notional Value at September 30, | $ | 96 | $ | 96 | ||||||||||||||||||||
Three months ended September 30: | ||||||||||||||||||||||||
Gain (loss) on instrument | (6 | ) | (3 | ) | ||||||||||||||||||||
Gain (loss) on hedged item | 6 | 3 | ||||||||||||||||||||||
Nine months ended September 30: | ||||||||||||||||||||||||
Gain (loss) on instrument | — | (4 | ) | |||||||||||||||||||||
Gain (loss) on hedged item | — | 4 | ||||||||||||||||||||||
Reconciliation of the Venezuelan investments at fair value | The following table presents a reconciliation of the fair value of the Venezuelan bonds for the nine months ended September 30, 2013 and 2012: | |||||||||||||||||||||||
2013 | 2012 | |||||||||||||||||||||||
Beginning balance as of January 1, | $ | 642 | $ | 236 | ||||||||||||||||||||
Unrealized gain (loss) on investment | (124 | ) | 14 | |||||||||||||||||||||
Purchases and sales during the period | 182 | 373 | ||||||||||||||||||||||
Ending balance as of September 30, | $ | 700 | $ | 623 | ||||||||||||||||||||
Acquisitions_and_Divestitures_
Acquisitions and Divestitures (Details) (USD $) | 3 Months Ended | 9 Months Ended | |||
In Millions, unless otherwise specified | Sep. 30, 2013 | Sep. 30, 2012 | Sep. 30, 2011 | Sep. 30, 2013 | Sep. 30, 2012 |
Sale of Land in Mexico [Abstract] | |||||
First Installment received from the sale of land in Mexico | $24 | ||||
Second Installment received from the sale of land in Mexico | 36 | ||||
Pretax costs related to sale of land | 3 | 7 | 14 | 20 | |
Aftertax costs related to sale of land | $2 | $5 | $9 | $15 |
Restructuring_and_Related_Impl2
Restructuring and Related Implementation Charges (Details) (Two Thousand Twelve Restructuring Program [Member], USD $) | 3 Months Ended | 9 Months Ended | 3 Months Ended | 9 Months Ended | 3 Months Ended | 9 Months Ended | 3 Months Ended | 9 Months Ended | |||||||||||
In Millions, unless otherwise specified | Sep. 30, 2013 | Sep. 30, 2013 | Dec. 31, 2012 | Sep. 30, 2013 | Sep. 30, 2013 | Sep. 30, 2013 | Sep. 30, 2013 | Sep. 30, 2013 | Sep. 30, 2013 | Sep. 30, 2013 | Sep. 30, 2013 | Sep. 30, 2013 | Sep. 30, 2013 | Sep. 30, 2013 | Sep. 30, 2013 | Sep. 30, 2013 | Jun. 30, 2013 | Sep. 30, 2013 | Jun. 30, 2013 |
One-time Termination Benefits [Member] | One-time Termination Benefits [Member] | Incremental Depreciation And Asset Impairment [Member] | Charges Resulting Directly From Exit Activities [Member] | Contract Termination [Member] | Contract Termination [Member] | Implementation Of New Strategies [Member] | Third party Incremental Cost [Member] | Third party Incremental Cost [Member] | Land and Building [Member] | Expected Completion Date 2016 | Expected Completion Date 2016 | Expected Completion Date December 2013 | Expected Completion Date December 2013 | Expected Completion Date December 2013 | Expected Completion Date December 2013 | ||||
Minimum [Member] | Maximum [Member] | Minimum [Member] | Minimum [Member] | Maximum [Member] | Maximum [Member] | ||||||||||||||
Restructuring Cost and Reserve [Line Items] | |||||||||||||||||||
Restructuring and Related Cost, Incurred Cost | $30 | $198 | $5 | $91 | $8 | $27 | $11 | $35 | $24 | ||||||||||
Duration Of Restructuring Program | 4 years | ||||||||||||||||||
Restructuring Program Expected Cost Before Tax | 1,100 | 1,250 | 365 | 260 | 390 | 310 | |||||||||||||
Restructuring Program Expected Cost After Tax | $775 | $875 | $290 | $185 | $305 | $220 | |||||||||||||
Estimated Percent Of Total Cumulative Pretax Charges Of Implementing 2012 Restructuring Program | 50.00% | 50.00% | 15.00% | 20.00% | 15.00% | ||||||||||||||
Percent of Restructuring Charges Resulting In Cash Expenditure | 75.00% | 75.00% |
Restructuring_and_Related_Impl3
Restructuring and Related Implementation Charges (Details 1) (Two Thousand Twelve Restructuring Program [Member], USD $) | 3 Months Ended | 9 Months Ended | 12 Months Ended |
In Millions, unless otherwise specified | Sep. 30, 2013 | Sep. 30, 2013 | Sep. 30, 2013 |
Restructuring Cost and Reserve [Line Items] | |||
Restructuring and Related Cost, Incurred Cost | $30 | $198 | |
Restructuring And Related Cost, Incurred Cost, After Tax | 22 | 153 | |
Restructuring and Related Cost, Cost Incurred to Date | 287 | ||
Restructuring And Related Cost, Incurred Cost to Date, After Tax | 223 | ||
One-time Termination Benefits [Member] | |||
Restructuring Cost and Reserve [Line Items] | |||
Restructuring and Related Cost, Incurred Cost | 5 | 91 | |
Restructuring and Related Cost, Cost Incurred to Date | 169 | ||
Incremental Depreciation [Member] | |||
Restructuring Cost and Reserve [Line Items] | |||
Restructuring and Related Cost, Incurred Cost | 5 | 20 | |
Restructuring and Related Cost, Cost Incurred to Date | 20 | ||
Asset Impairment [Member] | |||
Restructuring Cost and Reserve [Line Items] | |||
Restructuring and Related Cost, Incurred Cost | 0 | 1 | |
Restructuring and Related Cost, Cost Incurred to Date | 1 | ||
Other Restructuring [Member] | |||
Restructuring Cost and Reserve [Line Items] | |||
Restructuring and Related Cost, Incurred Cost | 20 | 86 | |
Restructuring and Related Cost, Cost Incurred to Date | 97 | ||
Pet Nutrition [Member] | |||
Restructuring Cost and Reserve [Line Items] | |||
Expected Percent Of Total Restructuring Charges Related To Segment for the duration of the program | 10.00% | 10.00% | 10.00% |
Percent Of Total Restructuring Charges Related To Segment for the period | 29.00% | 8.00% | |
PercentOfRestructuringChargesReportableSegmentProgramChargesIncurredToDate | 6.00% | ||
Corporate [Member] | |||
Restructuring Cost and Reserve [Line Items] | |||
Expected Percent Of Total Restructuring Charges Related To Segment for the duration of the program | 40.00% | 40.00% | 40.00% |
Percent Of Total Restructuring Charges Related To Segment for the period | 30.00% | 27.00% | |
PercentOfRestructuringChargesReportableSegmentProgramChargesIncurredToDate | 31.00% | ||
North America [Member] | |||
Restructuring Cost and Reserve [Line Items] | |||
Expected Percent Of Total Restructuring Charges Related To Segment for the duration of the program | 15.00% | 15.00% | 15.00% |
Percent Of Total Restructuring Charges Related To Segment for the period | 13.00% | 20.00% | |
PercentOfRestructuringChargesReportableSegmentProgramChargesIncurredToDate | 14.00% | ||
Latin America [Member] | |||
Restructuring Cost and Reserve [Line Items] | |||
Expected Percent Of Total Restructuring Charges Related To Segment for the duration of the program | 5.00% | 5.00% | 5.00% |
Percent Of Total Restructuring Charges Related To Segment for the period | 6.00% | 6.00% | |
PercentOfRestructuringChargesReportableSegmentProgramChargesIncurredToDate | 4.00% | ||
Europe/South Pacific [Member] | |||
Restructuring Cost and Reserve [Line Items] | |||
Expected Percent Of Total Restructuring Charges Related To Segment for the duration of the program | 20.00% | 20.00% | 20.00% |
Percent Of Total Restructuring Charges Related To Segment for the period | 22.00% | 35.00% | |
PercentOfRestructuringChargesReportableSegmentProgramChargesIncurredToDate | 42.00% | ||
Asia [Member] | |||
Restructuring Cost and Reserve [Line Items] | |||
Expected Percent Of Total Restructuring Charges Related To Segment for the duration of the program | 5.00% | 5.00% | 5.00% |
Africa/Eurasia [Member] | |||
Restructuring Cost and Reserve [Line Items] | |||
Expected Percent Of Total Restructuring Charges Related To Segment for the duration of the program | 5.00% | 5.00% | 5.00% |
Percent Of Total Restructuring Charges Related To Segment for the period | 4.00% | ||
PercentOfRestructuringChargesReportableSegmentProgramChargesIncurredToDate | 3.00% | ||
Cost of Sales [Member] | |||
Restructuring Cost and Reserve [Line Items] | |||
Restructuring and Related Cost, Incurred Cost | 8 | 26 | |
Selling, General and Administrative Expenses [Member] | |||
Restructuring Cost and Reserve [Line Items] | |||
Restructuring and Related Cost, Incurred Cost | 9 | 31 | |
Other (Income) Expense, Net [Member] | |||
Restructuring Cost and Reserve [Line Items] | |||
Restructuring and Related Cost, Incurred Cost | $13 | $141 |
Restructuring_and_Related_Impl4
Restructuring and Related Implementation Charges (Details 2) (Two Thousand Twelve Restructuring Program [Member], USD $) | 3 Months Ended | 9 Months Ended |
In Millions, unless otherwise specified | Sep. 30, 2013 | Sep. 30, 2013 |
Restructuring Reserve [Roll Forward] | ||
Balance | $172 | $89 |
Charges | 30 | 198 |
Cash payments | -51 | -103 |
Charges against assets | -5 | -38 |
Foreign exchange | 0 | 0 |
Balance | 146 | 146 |
One-time Termination Benefits [Member] | ||
Restructuring Reserve [Roll Forward] | ||
Balance | 141 | 84 |
Charges | 5 | 91 |
Cash payments | -40 | -52 |
Charges against assets | 0 | -17 |
Foreign exchange | 0 | 0 |
Balance | 106 | 106 |
Incremental Depreciation [Member] | ||
Restructuring Reserve [Roll Forward] | ||
Balance | 0 | 0 |
Charges | 5 | 20 |
Cash payments | 0 | 0 |
Charges against assets | -5 | -20 |
Foreign exchange | 0 | 0 |
Balance | 0 | 0 |
Asset Impairment [Member] | ||
Restructuring Reserve [Roll Forward] | ||
Balance | 0 | 0 |
Charges | 0 | 1 |
Cash payments | 0 | 0 |
Charges against assets | 0 | -1 |
Foreign exchange | 0 | 0 |
Balance | 0 | 0 |
Other Restructuring [Member] | ||
Restructuring Reserve [Roll Forward] | ||
Balance | 31 | 5 |
Charges | 20 | 86 |
Cash payments | -11 | -51 |
Charges against assets | 0 | 0 |
Foreign exchange | 0 | 0 |
Balance | $40 | $40 |
Inventories_Details
Inventories (Details) (USD $) | Sep. 30, 2013 | Dec. 31, 2012 |
In Millions, unless otherwise specified | ||
Inventory, Net [Abstract] | ||
Raw materials and supplies | $340 | $362 |
Work-in-process | 58 | 81 |
Finished goods | 1,043 | 922 |
Total Inventories | $1,441 | $1,365 |
Shareholders_Equity_Details
Shareholders' Equity (Details) (USD $) | 3 Months Ended | 9 Months Ended | |||
In Millions, unless otherwise specified | Sep. 30, 2013 | Sep. 30, 2012 | Sep. 30, 2013 | Sep. 30, 2012 | Dec. 31, 2012 |
Changes in Shareholders' Equity [Roll Forward] | |||||
Beginning balance | $2,390 | ||||
Net income | 699 | 697 | 1,809 | 1,995 | |
Other comprehensive income, net of tax | 106 | 107 | -102 | 24 | |
Ending balance | 2,007 | 2,007 | |||
Accumulated Other Comprehensive Income (Loss), Foreign Currency Translation Adjustment, Net of Tax | 1,767 | 1,767 | 1,609 | ||
Accumulated Other Comprehensive Income (Loss), Pension and Other Postretirement Benefit Plans, Net of Tax | 997 | 997 | 1,053 | ||
Common Stock [Member] | |||||
Changes in Shareholders' Equity [Roll Forward] | |||||
Beginning balance | 1,466 | ||||
Ending balance | 1,466 | 1,466 | 1,466 | ||
Additional Paid-In Capital [Member] | |||||
Changes in Shareholders' Equity [Roll Forward] | |||||
Beginning balance | 818 | ||||
Stock-based compensation expense | 105 | ||||
Shares issued for stock options | 64 | ||||
Stock issued for restricted stock awards | -72 | ||||
Other | -3 | ||||
Ending balance | 912 | 912 | |||
Unearned Compensation [Member] | |||||
Changes in Shareholders' Equity [Roll Forward] | |||||
Beginning balance | -41 | ||||
Other | 6 | ||||
Ending balance | -35 | -35 | |||
Treasury Stock [Member] | |||||
Changes in Shareholders' Equity [Roll Forward] | |||||
Beginning balance | -14,386 | ||||
Shares issued for stock options | 195 | ||||
Stock issued for restricted stock awards | 72 | ||||
Treasury stock acquired | -1,115 | ||||
Other | -2 | ||||
Ending balance | -15,236 | -15,236 | |||
Retained Earnings [Member] | |||||
Changes in Shareholders' Equity [Roll Forward] | |||||
Beginning balance | 16,953 | ||||
Net income | 1,677 | ||||
Dividends | -1,237 | ||||
Ending balance | 17,393 | 17,393 | |||
Accumulated Other Comprehensive Income (Loss) [Member] | |||||
Changes in Shareholders' Equity [Roll Forward] | |||||
Beginning balance | -2,621 | ||||
Other comprehensive income, net of tax | -95 | ||||
Ending balance | -2,716 | -2,716 | |||
Noncontrolling Interests [Member] | |||||
Changes in Shareholders' Equity [Roll Forward] | |||||
Beginning balance | 201 | ||||
Net income | 132 | ||||
Other comprehensive income, net of tax | -7 | ||||
Dividends | -108 | ||||
Other | 5 | ||||
Ending balance | $223 | $223 |
Earnings_Per_Share_Details
Earnings Per Share (Details) (USD $) | 3 Months Ended | 9 Months Ended | ||
In Millions, except Share data, unless otherwise specified | Sep. 30, 2013 | Sep. 30, 2012 | Sep. 30, 2013 | Sep. 30, 2012 |
Earnings Per Share Reconciliation [Abstract] | ||||
Net income attributable to Colgate-Palmolive Company | $656 | $654 | $1,677 | $1,874 |
Basic EPS | 656 | 654 | 1,677 | 1,874 |
Diluted EPS | $656 | $654 | $1,677 | $1,874 |
Weighted Average Number of Shares Outstanding, Diluted [Abstract] | ||||
Basic EPS (in shares) | 928,100,000 | 949,800,000 | 932,500,000 | 954,800,000 |
Stock options and restricted stock (in shares) | 8,800,000 | 8,600,000 | 8,900,000 | 8,100,000 |
Diluted EPS (in shares) | 936,900,000 | 958,400,000 | 941,400,000 | 962,900,000 |
Earnings Per Share, Basic and Diluted [Abstract] | ||||
Earnings Per Share, Basic | $0.71 | $0.69 | $1.80 | $1.96 |
Earnings Per Share, Diluted | $0.70 | $0.68 | $1.78 | $1.95 |
Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount | 1,956,750 | 1,214,526 | 703,219 | 1,259,888 |
Common_Stock_Split_Details
Common Stock Split (Details) (USD $) | 9 Months Ended | |
In Millions, except Per Share data, unless otherwise specified | Sep. 30, 2013 | Apr. 23, 2013 |
Common Stock Split, Pro Forma Information [Line Items] | ||
Stockholders' Equity Note, Stock Split, Conversion Ratio | 2 | |
Stockholders' Equity Note Percent of Dividend in Shares | 100.00% | |
Common Stock, Par or Stated Value Per Share | $1 | |
Common Stock [Member] | ||
Common Stock Split, Pro Forma Information [Line Items] | ||
Stock Issued During Period, Value, Stock Dividend | 733 | |
Adjustments to Additional Paid in Capital, Stock Split | 733 |
Other_Comprehensive_Income_Det
Other Comprehensive Income (Details) (USD $) | 3 Months Ended | 9 Months Ended | ||||||
In Millions, unless otherwise specified | Sep. 30, 2013 | Sep. 30, 2012 | Sep. 30, 2013 | Sep. 30, 2012 | ||||
Other Comprehensive Income (Loss) [Abstract] | ||||||||
Cumulative translation adjustments, before-tax | $82 | $79 | ($170) | ($26) | ||||
Cumulative translation adjustment, net-of-tax | 93 | 81 | -158 | -27 | ||||
Pension and other benefits: | ||||||||
Net actuarial gains (losses) and prior service costs arising during the period, before-tax | 1 | 13 | 4 | -19 | ||||
Net actuarial gains (losses) and prior service costs arising during the period, net-of-tax | 1 | 8 | 3 | -14 | ||||
Amortization of net actuarial loss, transition & prior service costs, before-tax | 27 | [1] | 27 | [1] | 82 | [1] | 76 | [1] |
Amortization of net actuarial loss, transition & prior service costs, net-of-tax | 17 | [1] | 17 | [1] | 53 | [1] | 49 | [1] |
Retirement Plan and other retiree benefit adjustments, before-tax | 28 | 40 | 86 | 57 | ||||
Retirement Plan and other retiree benefit adjustments, net-of-tax | 18 | 25 | 56 | 35 | ||||
Available-for-sale securities: | ||||||||
Unrealized gains (losses) on available-for-sale securities, before-tax | 4 | -8 | -124 | 14 | ||||
Unrealized gains (losses) on available-for-sale securities, net-of-tax | 3 | -5 | -79 | 9 | ||||
Reclassification of (gains) losses into net earnings on available-for-sale securities, before-tax | 0 | 0 | 133 | [2] | 0 | [2] | ||
Reclassification of (gains) losses into net earnings on available-for-sale securities, net-of-tax | 0 | 0 | 86 | [2] | 0 | [2] | ||
Gains (losses) on available-for-sale securities, before-tax | 4 | -8 | 9 | 14 | ||||
Gains (losses) on available-for-sale securities, net-of-tax | 3 | -5 | 7 | 9 | ||||
Cash flow hedges: | ||||||||
Unrealized gains (losses) on cash flow hedges, before-tax | 2 | -1 | 13 | 7 | ||||
Unrealized gains (losses) on cash flow hedges, net-of-tax | 0 | 0 | 8 | 5 | ||||
Reclassification of (gains) losses into net earnings on cash flow hedges, before-tax | -8 | [3] | -3 | [3] | -13 | [3] | -4 | [3] |
Reclassification of (gains) losses into net earnings on cash flow hedges, net-of-tax | -5 | [3] | -2 | [3] | -8 | [3] | -2 | [3] |
Gains (losses) on cash flow hedges, before-tax | -6 | -4 | 0 | 3 | ||||
Gains (losses) on cash flow hedges, net-of-tax | -5 | -2 | 0 | 3 | ||||
Total other comprehensive income (loss), before-tax | 108 | 107 | -75 | 48 | ||||
Total other comprehensive income (loss), net-of-tax | $109 | $99 | ($95) | $20 | ||||
[1] | These components of Other comprehensive income (loss) are included in the computation of net periodic benefit cost. See Note 11, Retirement Plans and Other Retiree Benefits for additional details. | |||||||
[2] | Represents the one-time loss related to the remeasurement of the fixed interest rate bonds in Venezuela which was recorded in Other (income) expense, net. See Note 14, Fair Value Measurements and Financial Instruments for additional details. | |||||||
[3] | These (gains) losses are reclassified into Cost of sales. See Note 14, Fair Value Measurements and Financial Instruments for additional details. |
Retirement_Plans_and_Other_Ret2
Retirement Plans and Other Retiree Benefits (Details) (USD $) | 3 Months Ended | 9 Months Ended | ||
In Millions, unless otherwise specified | Sep. 30, 2013 | Sep. 30, 2012 | Sep. 30, 2013 | Sep. 30, 2012 |
Defined Benefit Plan Disclosure [Line Items] | ||||
Defined Benefit Plan, Contributions by Employer | $101 | $101 | ||
United States Pension Benefits [Member] | ||||
Components of net periodic benefit cost | ||||
Service Cost | 6 | 4 | 20 | 18 |
Interest cost | 22 | 24 | 68 | 73 |
ESOP Offset | 0 | 0 | 0 | 0 |
Expected return on plan assets | -29 | -28 | -88 | -84 |
Amortization of transition and prior service costs (credits) | 1 | 2 | 6 | 7 |
Amortization of actuarial loss | 17 | 17 | 49 | 46 |
Net periodic benefit cost | 17 | 19 | 55 | 60 |
International Pension Benefits [Member] | ||||
Components of net periodic benefit cost | ||||
Service Cost | 6 | 6 | 16 | 17 |
Interest cost | 8 | 9 | 22 | 26 |
ESOP Offset | 0 | 0 | 0 | 0 |
Expected return on plan assets | -7 | -7 | -19 | -19 |
Amortization of transition and prior service costs (credits) | 1 | 1 | 1 | 1 |
Amortization of actuarial loss | 3 | 2 | 10 | 7 |
Net periodic benefit cost | 11 | 11 | 30 | 32 |
Other Retiree Benefits [Member] | ||||
Components of net periodic benefit cost | ||||
Service Cost | 3 | 2 | 10 | 8 |
Interest cost | 8 | 9 | 28 | 30 |
ESOP Offset | 0 | 0 | -1 | -1 |
Expected return on plan assets | -1 | -1 | -2 | -2 |
Amortization of transition and prior service costs (credits) | 0 | 0 | 0 | 2 |
Amortization of actuarial loss | 5 | 5 | 16 | 13 |
Net periodic benefit cost | $15 | $15 | $51 | $50 |
Contingencies_Details
Contingencies (Details) (USD $) | 9 Months Ended | |
In Millions, unless otherwise specified | Sep. 30, 2013 | Oct. 09, 2013 |
Loss Contingency [Abstract] | ||
Minimum Number Of Countries And Territories Serving Consumers | 200 | |
Range of reasonably possible losses, minimum | $0 | |
Range of reasonably possible losses, maximum | 250 | |
Brazilian internal revenue authority, matter 1 | 120 | |
Brazilian internal revenue authority, matter 2 | 75 | |
European competition matters - Swiss competition law authority | 6 | |
European competition matters - Spanish competition law authority | 3 | |
European competition matters - Italian competition law authority | 3 | |
European competition matters - French competition law authority | 46 | |
European competition matters - Hill's France Subsidiary | 7 | |
ERISA Matter | $40 |
Segment_Information_Details
Segment Information (Details) (USD $) | 3 Months Ended | 9 Months Ended | |||
In Millions, unless otherwise specified | Sep. 30, 2013 | Mar. 31, 2013 | Sep. 30, 2012 | Sep. 30, 2013 | Sep. 30, 2012 |
Notes to Financial Statements [Abstract] | |||||
Percentage Of Consolidated Net sales Represented By Caricom and Puerto Rico Subsidiary | 1.00% | ||||
Percentage Of North America's Net sales Represented By Caricom and Puerto Rico Subsidiary | 4.00% | ||||
Percentage Of Latin America's Net sales Represented By Caricom and Puerto Rico Subsidiary | 3.00% | ||||
Segment Reporting Information [Line Items] | |||||
Pretax costs related to sale of land | $3 | $7 | $14 | $20 | |
Pretax Venezuela devaluation charge | 172 | 0 | |||
Charge for French Competition Law Matter | 18 | ||||
Costs before tax associated with various Business Realignment and other cost-saving initiatives | 3 | 21 | |||
Total Net sales | 4,398 | 4,332 | 13,059 | 12,799 | |
Total Operating profit | 1,016 | 1,027 | 2,664 | 2,947 | |
Operating Segments [Member] | Oral, Personal and Home Care [Member] | |||||
Segment Reporting Information [Line Items] | |||||
Total Net sales | 3,853 | 3,804 | 11,431 | 11,198 | |
Total Operating profit | 1,057 | 1,019 | 3,038 | 2,911 | |
Operating Segments [Member] | Pet Nutrition [Member] | |||||
Segment Reporting Information [Line Items] | |||||
Total Net sales | 545 | 528 | 1,628 | 1,601 | |
Total Operating profit | 138 | 147 | 410 | 440 | |
Operating Segments [Member] | North America [Member] | Oral, Personal and Home Care [Member] | |||||
Segment Reporting Information [Line Items] | |||||
Total Net sales | 774 | 766 | 2,300 | 2,217 | |
Total Operating profit | 244 | 213 | 686 | 580 | |
Operating Segments [Member] | Latin America [Member] | Oral, Personal and Home Care [Member] | |||||
Segment Reporting Information [Line Items] | |||||
Total Net sales | 1,251 | 1,276 | 3,747 | 3,777 | |
Total Operating profit | 358 | 377 | 1,022 | 1,100 | |
Operating Segments [Member] | Europe/South Pacific [Member] | Oral, Personal and Home Care [Member] | |||||
Segment Reporting Information [Line Items] | |||||
Total Net sales | 880 | 865 | 2,552 | 2,569 | |
Total Operating profit | 216 | 198 | 605 | 560 | |
Operating Segments [Member] | Asia [Member] | Oral, Personal and Home Care [Member] | |||||
Segment Reporting Information [Line Items] | |||||
Total Net sales | 627 | 583 | 1,900 | 1,717 | |
Total Operating profit | 174 | 164 | 533 | 474 | |
Operating Segments [Member] | Africa/Eurasia [Member] | Oral, Personal and Home Care [Member] | |||||
Segment Reporting Information [Line Items] | |||||
Total Net sales | 321 | 314 | 932 | 918 | |
Total Operating profit | 65 | 67 | 192 | 197 | |
Corporate, Non-Segment [Member] | Corporate, Non-Segment [Member] | |||||
Segment Reporting Information [Line Items] | |||||
Total Operating profit | -179 | -139 | -784 | -404 | |
Two Thousand Twelve Restructuring Program [Member] | |||||
Segment Reporting Information [Line Items] | |||||
Restructuring and Related Cost, Incurred Cost | $30 | $198 | |||
Sales Revenue, Net [Member] | |||||
Segment Reporting Information [Line Items] | |||||
Percentage of Consolidated Net Sales represented by Sales outside US | 80.00% | 80.00% | |||
Percentage of Consolidated Net Sales coming from Emerging Markets | 50.00% | 50.00% |
Fair_Value_Measurements_and_Fi2
Fair Value Measurements and Financial Instruments (Details 1) (USD $) | Sep. 30, 2013 | Dec. 31, 2012 |
In Millions, unless otherwise specified | ||
Derivative and Financial Instruments, Fair Value [Line Items] | ||
Total assets derivatives | $35 | $65 |
Total liabilities derivatives | 12 | 11 |
Financial Instruments, Owned, at Fair Value [Abstract] | ||
Total other financial instruments | 822 | 734 |
Designated derivative instruments | ||
Derivative Assets | 35 | 65 |
Derivative Liabilities | 11 | 10 |
Derivative Instruments Not Designated as Hedging Instruments [Abstract] | ||
Derivative Instruments Not Designated as Hedging Instruments, Asset, at Fair Value | 0 | 0 |
Derivative Instruments Not Designated as Hedging Instruments, Liability, at Fair Value | 1 | 1 |
Other Current Assets [Member] | ||
Derivative and Financial Instruments, Fair Value [Line Items] | ||
Marketable Securities | 146 | 116 |
Interest Rate Swap Contracts [Member] | Other Current Assets [Member] | ||
Designated derivative instruments | ||
Derivative Assets | 1 | 3 |
Interest Rate Swap Contracts [Member] | Other Assets [Member] | ||
Designated derivative instruments | ||
Derivative Assets | 22 | 41 |
Interest Rate Swap Contracts [Member] | Other Accruals [Member] | ||
Designated derivative instruments | ||
Derivative Liabilities | 0 | 0 |
Interest Rate Swap Contracts [Member] | Other Liabilities [Member] | ||
Designated derivative instruments | ||
Derivative Liabilities | 0 | 0 |
Foreign Currency Contracts [Member] | Other Current Assets [Member] | ||
Designated derivative instruments | ||
Derivative Assets | 9 | 7 |
Derivative Instruments Not Designated as Hedging Instruments [Abstract] | ||
Derivative Instruments Not Designated as Hedging Instruments, Asset, at Fair Value | 0 | 0 |
Foreign Currency Contracts [Member] | Other Assets [Member] | ||
Designated derivative instruments | ||
Derivative Assets | 3 | 13 |
Foreign Currency Contracts [Member] | Other Accruals [Member] | ||
Designated derivative instruments | ||
Derivative Liabilities | 10 | 10 |
Derivative Instruments Not Designated as Hedging Instruments [Abstract] | ||
Derivative Instruments Not Designated as Hedging Instruments, Liability, at Fair Value | 1 | 1 |
Foreign Currency Contracts [Member] | Other Liabilities [Member] | ||
Designated derivative instruments | ||
Derivative Liabilities | 1 | 0 |
Commodity Contracts [Member] | Other Current Assets [Member] | ||
Designated derivative instruments | ||
Derivative Assets | 0 | 1 |
Commodity Contracts [Member] | Other Accruals [Member] | ||
Designated derivative instruments | ||
Derivative Liabilities | 0 | 0 |
Available for Sale Securities | Other Assets [Member] | ||
Financial Instruments, Owned, at Fair Value [Abstract] | ||
Available-for-sale Securities, Fair Value Disclosure | $676 | $618 |
Fair_Value_Measurements_and_Fi3
Fair Value Measurements and Financial Instruments (Details 2) (USD $) | Sep. 30, 2013 | Dec. 31, 2012 |
In Millions, unless otherwise specified | ||
Fair Value, Inputs, Level 2 [Member] | ||
Debt Instrument [Line Items] | ||
Debt Instrument, Fair Value Disclosure | $5,465 | $5,484 |
Carrying Value [Member] | ||
Debt Instrument [Line Items] | ||
Long-term debt | $5,265 | $5,176 |
Fair_Value_Measurements_and_Fi4
Fair Value Measurements and Financial Instruments (Details 3) (USD $) | 3 Months Ended | 9 Months Ended | ||
In Millions, unless otherwise specified | Sep. 30, 2013 | Sep. 30, 2012 | Sep. 30, 2013 | Sep. 30, 2012 |
Fair Value Hedging [Member] | ||||
Derivative Instruments, Gain (Loss) [Line Items] | ||||
Derivative, Notional Amount | $2,656 | $2,282 | $2,656 | $2,282 |
Activity related to fair value hedges [Abstract] | ||||
Gain (loss) on derivative | -7 | -3 | -15 | 14 |
Gain (loss) on hedged items | 7 | 3 | 15 | -14 |
Fair Value Hedging [Member] | Foreign Currency Contracts [Member] | ||||
Derivative Instruments, Gain (Loss) [Line Items] | ||||
Derivative, Notional Amount | 1,568 | 944 | 1,568 | 944 |
Activity related to fair value hedges [Abstract] | ||||
Gain (loss) on derivative | -9 | -8 | 3 | 2 |
Gain (loss) on hedged items | 9 | 8 | -3 | -2 |
Fair Value Hedging [Member] | Interest Rate Swap Contracts [Member] | ||||
Derivative Instruments, Gain (Loss) [Line Items] | ||||
Derivative, Notional Amount | 1,088 | 1,338 | 1,088 | 1,338 |
Activity related to fair value hedges [Abstract] | ||||
Gain (loss) on derivative | 2 | 5 | -18 | 12 |
Gain (loss) on hedged items | -2 | -5 | 18 | -12 |
Cash Flow Hedging [Member] | ||||
Derivative Instruments, Gain (Loss) [Line Items] | ||||
Derivative, Notional Amount | 456 | 373 | 456 | 373 |
Activity related to cash flow hedges [Abstract] | ||||
Gain (loss) recognized in OCI | 2 | -1 | 13 | 7 |
Gain (loss) reclassified into Cost of sales | 8 | 3 | 13 | 4 |
Cash Flow Hedging [Member] | Foreign Currency Contracts [Member] | ||||
Derivative Instruments, Gain (Loss) [Line Items] | ||||
Derivative, Notional Amount | 441 | 347 | 441 | 347 |
Activity related to cash flow hedges [Abstract] | ||||
Gain (loss) recognized in OCI | 2 | -7 | 13 | -4 |
Gain (loss) reclassified into Cost of sales | 8 | -1 | 12 | 0 |
Cash Flow Hedging [Member] | Commodity Contracts [Member] | ||||
Derivative Instruments, Gain (Loss) [Line Items] | ||||
Derivative, Notional Amount | 15 | 26 | 15 | 26 |
Activity related to cash flow hedges [Abstract] | ||||
Gain (loss) recognized in OCI | 0 | 6 | 0 | 11 |
Gain (loss) reclassified into Cost of sales | 0 | 4 | 1 | 4 |
Net Investment Hedging [Member] | ||||
Derivative Instruments, Gain (Loss) [Line Items] | ||||
Derivative, Notional Amount | 795 | 823 | 795 | 823 |
Activity related to net investment hedges [Abstract] | ||||
Gain (loss) on instruments | -27 | -8 | -8 | 4 |
Gain (loss) on hedged items | 27 | 10 | 9 | -7 |
Net Investment Hedging [Member] | Foreign Currency Contracts [Member] | ||||
Derivative Instruments, Gain (Loss) [Line Items] | ||||
Derivative, Notional Amount | 557 | 527 | 557 | 527 |
Activity related to net investment hedges [Abstract] | ||||
Gain (loss) on instruments | -18 | -6 | -8 | 2 |
Gain (loss) on hedged items | 18 | 8 | 9 | -5 |
Net Investment Hedging [Member] | Foreign Currency Denominated Debt [Member] | ||||
Derivative Instruments, Gain (Loss) [Line Items] | ||||
Derivative, Notional Amount | 238 | 296 | 238 | 296 |
Activity related to net investment hedges [Abstract] | ||||
Gain (loss) on instruments | -9 | -2 | 0 | 2 |
Gain (loss) on hedged items | 9 | 2 | 0 | -2 |
Not Designated as Hedging Instrument [Member] | Cross-Currency Swap [Member] | ||||
Derivative Instruments, Gain (Loss) [Line Items] | ||||
Derivative, Notional Amount | 96 | 96 | 96 | 96 |
Activity related to derivatives not designated as hedging instruments [Abstract] | ||||
Gain (loss) on instrument | -6 | -3 | 0 | -4 |
Gain (loss) on hedged item | $6 | $3 | $0 | $4 |
Fair_Value_Measurements_and_Fi5
Fair Value Measurements and Financial Instruments (Details 4) (USD $) | 3 Months Ended | |||||||||||
In Millions, unless otherwise specified | Mar. 31, 2013 | Sep. 30, 2013 | Sep. 30, 2013 | Dec. 31, 2012 | Sep. 30, 2012 | Dec. 31, 2010 | Sep. 30, 2013 | Dec. 31, 2012 | Sep. 30, 2013 | Sep. 30, 2013 | Sep. 30, 2013 | Dec. 31, 2012 |
Bonds Issued By Venezuelan Government [Member] | Bonds Issued By Venezuelan Government [Member] | Bonds Issued By Venezuelan Government [Member] | Bonds Issued By Venezuelan Government [Member] | Other Current Assets [Member] | Other Current Assets [Member] | Other Current Assets [Member] | Other Current Assets [Member] | Other Assets [Member] | Other Assets [Member] | |||
Fair Value Inputs Level1 | Bonds Issued By Venezuelan Government [Member] | Available for Sale Securities | Available for Sale Securities | |||||||||
Schedule of Available-for-sale Securities [Line Items] | ||||||||||||
Marketable Securities | $146 | $116 | $122 | $24 | ||||||||
Available-for-sale Securities | 700 | 642 | 623 | 236 | 676 | 618 | ||||||
Fair Value of U.S. dollar-linked, devaluation-protected bonds | 257 | |||||||||||
Fair Value of fixed interest rate bonds | 443 | |||||||||||
One-time loss related to the remeasurement of fixed interest rate bonds in Venezuela | $133 |
Fair_Value_Measurements_and_Fi6
Fair Value Measurements and Financial Instruments (Details 5) (Bonds Issued By Venezuelan Government [Member], USD $) | 9 Months Ended | ||
In Millions, unless otherwise specified | Sep. 30, 2013 | Sep. 30, 2012 | Dec. 31, 2010 |
Bonds Issued By Venezuelan Government [Member] | |||
Venezuelan Investments [Roll Forward] | |||
Beginning balance | $642 | $236 | |
Unrealized gain (loss) on investment | -124 | 14 | |
Purchases and sales during the period | 182 | 373 | |
Ending balance | $700 | $623 | $236 |
Venezuela_Details
Venezuela (Details) | 9 Months Ended | ||
In Millions, except Per Share data, unless otherwise specified | Sep. 30, 2013 | Sep. 30, 2012 | Sep. 30, 2013 |
USD ($) | USD ($) | VEF | |
Notes to Financial Statements [Abstract] | |||
Official currency exchange rate in Venezuela for non-essential goods prior to devaluation beginning Febrauary 13, 2013 | 4.3 | ||
Official currency exchange rate in Venezuela for non-essential goods beginning February 13, 2013 | 6.3 | ||
Pretax Venezuela devaluation charge | $172 | $0 | |
Aftertax Venezuela devaluation charge | 111 | ||
Impact of aftertax Venezuela devaluation charge per common share diluted | $0.12 | ||
Percentage of consolidated Net sales represented by CP Venezuela (in hundredths) | 4.00% | ||
CP Venezuela's bolivar fuerte-denominated monetary net asset position | 530 | ||
Fair Value of U.S. dollar-linked, devaluation-protected bonds | $257 |